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Abstract 
Over the past 50 years, cardiac pacemakers have been used to treat 
bradycardia such as complete heart block, with single chamber pacing, 
then dual chamber pacing with the advantage of atrioventricular synchrony 
and more recently the development of biventricular pacing for heart failure, 
severely impaired left ventricular function and left bundle branch block.  
Throughout this pacemaker therapy has been designed to approach normal 
physiology.  Indeed biventriuclar pacing is conceived as resynchronisation 
therapy, and is commonly referred to as such. 
Alongside such developments in pacemaker therapy, real-time three-
dimensional echocardiography has emerged as a technique to accurately 
measure left ventricular function and assess dyssynchrony. 
This thesis uses this technique in four discrete projects.  The first 
investigated the optimal timing of pacing stimuli compared to impedance 
and invasive haemodynamics.  The second investigated mid-septal as 
compared to conventional right ventricular pacing.  The third investigated 
the utility of dyssynchrony assessment after biventricular pacing to predict 
medium term response and the need for optimisation.  The final chapter 
investigated the reliability and reproducibility of novel three-dimensional 
speckle tracking techniques. 
The concordance of impedance, haemodynamic and echocardiographic 
measurements in selecting the optimum atrioventricular pacing interval was 
poor.  Right ventricular pacing resulted in an acute decrement in left 
ventricular function, particularly in patients with pre-existing left ventricular 
dysfunction.  In these patients mid-septal pacing caused less of a decline in 
left ventricular function than apical pacing.  The assessment of 
dyssynchrony after biventricular pacemaker therapy was a powerful 
predictor of medium term response, as well as identifying a group of 
patients with a higher probability of acute response to optimisation of 
timing of pacing stimuli.  Novel three-dimensional speckle tracking 
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methods have good reproducibility for calculation of left ventricular 
volumes, but not for dyssynchrony measurements.  After training and with 
better quality datasets, reproducibility is improved. 
Three-dimensional echocardiography is an attractive technique in the 
evaluation of patients with pacemakers.  Some of the changes induced by 
altering pacemaker settings are near the limit of resolution of the technique.  
Speckle tracking is attractive and the improvement in software may improve 
its reliability and utility. 
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Chapter 1  Introduction 
1.1  Abstract 
In recent years biventricular pacing has emerged as a treatment for 
patients with heart failure, systolic left ventricular dysfunction and left 
bundle branch block.  The mechanism of this treatment is generally 
accepted to be the amelioration of dyssynchronous cardiac contraction.  It 
has therefore focussed attention to the assessment of cardiac dyssynchrony 
as well as the effect of right ventricular pacing on dyssynchrony and cardiac 
function. 
Over the same period advances in echocardiography have led to the 
development of 3-dimensional techniques in the assessment of cardiac 
function and dyssynchrony.  This thesis uses these methods to investigate 
their use in determining optimal timing of biventricular pacing, to 
determine the effects of pacing the right ventricle in different sites, the 
prediction of benefit from optimisation of timing of biventricular pacing as 
well as evaluating the reproducibility and the determinants of this in novel 
methods of 3D echocardiographic analysis. 
The rest of this introduction will briefly review the history of pacing, 
define dyssynchrony and describe techniques used in its assessment before 
covering the effects of left bundle branch block, right ventricular pacing 
and biventricular pacing on dyssynchrony.  Finally I will review the 
development and evidence base for biventricular pacing and the evidence 
behind optimisation of timing of pacing.  Novel speckle tracking methods 
will be mentioned and the chapter will close with the open questions that 
this thesis answers. 
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1.2  History of pacing 
In 1889 Andrew McWilliam made the discovery that regular electrical 
impulses caused cardiac contractions in cats and dogs1.  Later in the 1920’s 
Dr Mark Lidwell, an Australian anaesthetist attempted to use electrical 
impulses delivered via a needle electrode to revive stillborn infants.  One 
such infant apparently did not respond to adrenaline therapy but underwent 
pacing for 10 minutes before regaining spontaneous circulation and 
surviving2.  In the 1920’s Hyman in New York, created a device to deliver 
electrical stimuli to the heart,  but this did not generate sufficient current to 
be practicable.  In the 1940’s Bigelow in Canada was working on the use of 
hypothermia to reduce metabolism and allow cardiac surgery.  
Hypothermia of 21 degrees Celsius resulted in asystole but the heart could 
not be re-started by warming.  This led to the development of the first 
catheter electrode to allow atrial pacing and control of the heart rate in 
animals3.   In 1952, Zoll reported his experience with external 
transcutaneous pacing in 2 patients, one of whom recovered an 
idioventricular rhythm and survived until discharge4.  Lillehei in Minnesota 
started to develop a system to be used during cardiac surgery.  Both Zoll 
and Lillehei’s apparatus was dependent on external stimulators and mains 
electricity.  Lillehei collaborated with a medical engineer Earl Bakken to 
develop the worlds first battery powered pacemaker.  This was successfully 
used in a child for a few days until it was removed after the recovery of 
spontaneous rhythm.  The first person to have a completely internal 
pacemaker system implanted was Arne Larsson in Sweden.  He had 
complete heart block and his wife persuaded Ake Senning and Rune 
Elmqvist to create and implant a pacemaker5.  This device used an 
epicardial electrode.  Although this only lasted 8 hours before it needed 
replacement, Mr Larsson went on to have a total of 26 pacemakers before 
dying at the age of 85 due to non-cardiac causes6. 
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Subsequently, Furman reported temporary transvenous pacing of the 
right ventricle in 2 patients, with the electrode site being either the right 
ventricular apex or the right ventricular outflow tract7. 
The first pacemakers simply delivered regular electrical stimuli, to a 
single cardiac chamber.  Improvements have led to the ability to sense 
intrinsic cardiac electrical activity, and thus inhibit or indeed trigger 
pacemaker stimulation, activity sensors so that the pacing rate can be 
altered to meet changing physiological demands, dual chamber 
pacemakers and biventricular pacemakers{Mohee:uz}. 
Developments in battery and lead technology allowed for a system to be 
placed transvenously, with leads placed in the right ventricle and, with the 
advent of dual chamber devices a further lead in the right atrium.  The right 
ventricular apex became the default location for transvenous ventricular 
pacing because lead angulation, trabeculations and gravity meant that this 
location was the least likely to be complicated by lead displacement8. 
Ever since the development of the pacemaker, there has been 
tremendous interest in maximising the benefit and minimising the 
complications of pacing.  One of the major themes is making pacing as 
physiological as possible.  The most obvious example is that of rhythm - the 
initial single chamber pacemakers meant that the ventricular rate was 
independent of the sinus rate.  Pacemaker syndrome - a constellation of 
symptoms and signs due to discordant atrioventricular contraction was first 
described in 19699.  Intuitively, dual chamber pacemakers would better 
approximate sinus rhythm and therefore ameliorate pacemaker syndrome 
and improve clinical outcomes.  However, overt symptoms of pacemaker 
syndrome are not seen in the majority of patients with single chamber 
pacemakers.  Therefore it was initially unclear if dual chamber pacing 
would bring benefits to the majority of patients requiring pacemakers.  Dual 
chamber pacing poses an additional cost, the procedure is more complex, 
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takes longer, has a higher infection rate, prolongs follow up visits and adds 
the risk of pacemaker mediated tachycardia. 
Physiological studies have demonstrated higher left ventricular end-
diastolic pressures, higher systolic and mean blood pressure, and lower 
right atrial and pulmonary capillary wedge pressures, as well as an increase 
in cardiac output with AV sequential pacing compared to with single 
chamber ventricular pacing.  A number of small crossover trials compared 
AV sequential pacing modes to fixed-rate ventricular pacing and later 
against rate-adaptive ventricular pacing.  Dual chamber pacing improves 
effort tolerance compared with fixed-rate ventricular pacing, but not 
compared to rate-adaptive ventricular pacing indicating that the increase in 
heart rate with exercise has a greater physiological impact than AV 
synchrony.  Similarly, several crossover studies compared quality of life 
between dual chamber and ventricular pacing.  Although very few of these 
studies used standardised or validated quality of life assessments, they did 
demonstrate improvements in quality of life with dual-chamber over 
ventricular pacing10. 
Observational studies have also implied that dual-chamber pacing 
reduces the risk of atrial fibrillation, stroke and death compared with 
ventricular pacing.  Indeed the largest of these studies reported in 1995 on 
outcomes of over 36,000 patients and suggested a mortality benefit from 
dual chamber pacing11.  It was in the context of physiological data, 
crossover and observational studies that guidelines issued by the British 
Pacing and Electrophysiology Group, as well as the American Heart 
Association and American College of Cardiology favoured the implantation 
of dual chamber pacemakers in patients without chronic atrial 
fibrillation12,13.   
However, it was only in 1994 that the first randomised controlled trial 
demonstrated a demonstrated a reduction in stroke with atrial pacing as 
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compared to ventricular pacing in sick-sinus syndrome14 with longer term 
follow up of the same cohort demonstrating lower mortality in the atrial 
pacing group15.  Despite the guidelines in favour of dual chamber pacing, a 
series of randomised controlled trial comparing single chamber ventricular 
pacing against dual-chamber pacing were performed - PASE16, CTOPP17,18 
MOST19 and UKPACE20 - which failed to show a mortality benefit from dual 
chamber pacing, though in CTOPP and MOST there was a reduction in 
atrial fibrillation, but not stroke.  Nevertheless when patients were able to 
choose programming a pacemaker to single chamber or dual chamber 
pacing, they preferred dual chamber pacing16. 
Simultaneously, work was being performed to investigate if patients with 
heart failure and without a conventional bradycardia indication for pacing, 
would benefit from pacemaker therapy.  The concept behind this was that 
in heart failure there is frequently prolongation of the pr interval suggesting 
imperfect co-ordination of atrial and ventricular contraction that could 
potentially be ameliorated by pacing.  Initial reports suggested remarkable 
early21,22 and late23 benefit.  However, data from patients who were being 
considered for cardiac transplantation and had a permanent pacemaker  
suggested that their outcomes were significantly worse than matched 
patients without a pacemaker24.  The authors suggested that this might be 
due to inappropriate pacing on under-sensed ventricular ectopics leading to 
an increased risk of ventricular fibrillation, or due to the effects of pacing 
induced dyssynchrony.  
The DAVID trial was the first large study to demonstrate clinical adverse 
events associated with RV apical pacing25.  This trial randomised patients 
without an indication for pacemaker therapy but undergoing implant of a 
defibrillator to a strategy of dual chamber rate-responsive pacing at a lower 
rate of 70 beats per minute or ventricular back up pacing at a rate of 40 
beats per minute.  They found that the back up pacing mode was associated 
with a lower rate of mortality and hospitalisation for heart failure.  
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The MOST trial confirmed the adverse clinical effects of right ventricular 
apical pacing.  This trial randomised 2010 patients with sinus node disease 
to dual or single chamber rate responsive pacing.  Overall, there was no 
difference in outcomes between the groups19, however when the 
population was studied on the basis of the percentage of ventricular pacing, 
it became clear that there was a relationship between the frequency of 
ventricular pacing and the risk of heart failure optimisation26.  This was 
different for the two modes.  In DDDR mode, there was a linear 
relationship between a ventricular pacing frequency from 0% to 40% after 
which the risk reached a plateau; in VVIR mode the linear relationship held 
from 0% to 80%.  Ventricular pacing was also associated with an increased 
risk of atrial fibrillation. 
These data have led to studies to understand the mechanism for these 
deleterious effects, strategies to minimise right ventricular pacing27 where 
possible and to investigate the utility of pacing alternative right ventricular 
sites.  These themes will be explored in greater detail below. 
The concept that biventricular stimulation could resynchronise the heart 
was demonstrated in man by Cazeau and others in 199428.  They reported 
on a single case of a 54 year old man with dilated cardiomyopathy in 
whom pacing of all 4 cardiac chambers resulted in acute haemodynamic 
improvement and significant clinical benefit after only 6 weeks of therapy.  
They hypothesised that the benefit was derived from both ventricular 
resynchronisation as well as optimising the atrioventricular sequence of 
contraction on both sides of the heart.  Later clinical studies including 
MUSTIC29,30, MIRACLE31, PATH-CHF32, COMPANION33, CARE-HF34 and 
MADI-CRT35 demonstrated significant improvements in morbidity and 
mortality in patients with heart failure, significantly impaired left ventricular 
function and left bundle branch block.  This therapy has come to be known 
as cardiac resynchronisation therapy or CRT, and the strong evidence from 
these randomised controlled trials has led to its adoption in international 
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guidelines. 36  However, even in these trials it has been noted that up to 
30% of patients do not derive symptomatic benefit from CRT. 
1.3  Definition of dyssynchrony 
Dyssynchrony refers to imperfect timing of the activity of different parts 
of the heart.  It can be thought of as occurring at three levels, atrio-
ventricular, inter-ventricular and intra-ventricular37.  Atrio-ventricular 
dyssynchrony refers to the lack of co-ordination in timing between atrial 
contraction and ventricular contraction.  At its worst, this can lead to the 
atrium contracting against a closed mitral valve, which leads to gross 
elevation of the atrial pressure visible as “cannon waves” in the jugular 
veins.  At a more subtle level, imperfect timing of atrial and ventricular 
contraction means that work done in atrial contraction is not completely 
translated into maximal left ventricular filling.  Inter-ventricular 
dyssynchrony describes differences in the timing between right and left 
ventricular contraction or relaxation.  Finally intra-ventricular dyssynchrony 
refers to differences in segmental timing within the ventricle.  Most of the 
focus for investigation has been on the left ventricle rather than the right 
ventricle, and a great deal of data has been accumulated in the context of 
left bundle branch block, heart failure, right ventricular and biventricular 
pacing.  A further distinction can be made between electrical and 
mechanical dyssynchrony, as these are not necessarily concordant. 
1.4  Techniques to assess dyssynchrony 
There are a number of techniques that have been used in the assessment 
of dyssynchrony.  They can be divided into indirect methods that measure 
the functional consequences of dyssynchrony, and those that attempt to 
characterise myocardial mechanics directly.  The latter techniques have 
generally been applied to intra-ventricular dyssynchrony. 
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1.4.1  Indirect techniques 
Clinical examination by an astute observer can reveal cannon waves in 
the jugular venous pressure as well as variations in the character of the 
pulse that may occur with the variations in filling seen in atrio-ventricular 
dyssynchrony, or reverse splitting of the second heart sounds indicating 
inter-ventricular dyssynchrony.  Clinical examination is not sensitive 
enough to detect intra-ventricular dyssynchrony. 
Phono-cardiography is a development of clinical examination which 
uses microphones to accurately record the heart sounds.  This can give 
information on the timing of heart valve closure and thus inter-ventricular 
dyssynchrony.  Invasive jugular venous and intra-cardiac pressure 
measurements can be made and parameters obtained including peak 
pressures, their time as well as the rate of change of pressure.  The rate of 
change of pressure at the beginning of systole has been used as an index of 
ventricular performance, but this is dependent on the cardiac pre-load.  If 
combined with simultaneous volume measurements, the cardiac workload 
can be accurately calculated from pressure-volume loops.  Pressure 
gradients can also be estimated non-invasively using Doppler 
echocardiography, though these measurements are angle dependent.  There 
are also numerous methods to measure cardiac output which is a global 
measure that is impaired by dyssynchrony.  These include invasive dilution 
cardiac output measurements, arterial pulse pressure contour 
measurements, the rate of change of left ventricular pressure, as well as 
non-invasive measurements using thoracic impedance, finger 
plethysmography as well as Doppler echocardiography. 
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1.4.2  Direct Techniques - electrical 
1.4.2.1  Electrocardiogram (ECG) 
Myocardial contraction is dependent on intracellular calcium flux, 
which is triggered by rhythmic alterations in the voltage gradient across 
individual myocardial fibres.  The changes in voltage across individual 
fibres sum to create a wave of electrical activity that is detectable on the 
surface of the body.  Einthoven developed the string galvanometer in the 
early 20th century which was sensitive enough to detect and record the 
electrical changes that occur on the body surface with individual heart 
beats{Barold:2003vy}.  Einthoven termed the deflection of the ECG due to 
atrial depolarisation the p wave and that of ventricular depolarisation the 
QRS complex.  In healthy subjects the QRS complex lasts approximately 80 
milliseconds.  This rapid depolarisation of the ventricles is dependent upon 
specialised conduction fibres within the heart which have a distinct 
anatomical organisation, arising from the atrioventricular node and forming 
the His bundle, before dividing into a right and left bundles.  The left 
bundle is further subdivided into anterior and posterior fascicles which 
terminate in sub-endocardial branches.  The right bundle directly 
terminates in sub-endocardial branches. 
The relationship of these intervals is one of the earliest measures of 
dyssynchrony.  Prolongation of basic intervals such as that of the between p 
wave and QRS complex is indicative of atrio-ventricular dyssynchrony.  
Prolongation of the QRS duration is indicative of inter and intra-ventricular 
dyssynchrony.  The pattern of the QRS complex gives further information 
than the duration alone - for example right bundle branch block indicating 
that the right ventricle is being activated later than the left ventricle,. 
Infrequently, healthy subjects may have prolongation of the QRS in a 
pattern that reflects right bundle branch block38 or rarely left bundle branch 
block39.  In patients with heart failure, the presence of bundle branch block 
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is much higher40, as is prolongation of the interval between atrial and 
ventricular depolarisation41.  The ECG can therefore given information on 
electrical dyssynchrony at all levels.  However, the relationship between 
electrical and mechanical dyssynchrony may not be fixed, but rather 
variable between patients. 
The surface ECG has been extended by the ability to make intracardiac 
recordings.  The use of recordings from multiple intracardiac locations 
allows for accurate mapping of electrical activation patterns, though with 
anatomical locations determined by fluoroscopy which may be relatively 
crude.    Electro-anatomical and non-contact mapping have been designed 
to improve this which allow the precise 3-dimensional location of the 
catheter in relation to a magnetic or electrical field to be determined.   
These systems can allow the import of previously acquired CT or MRI 
images of the heart to reduce the need for point-by-point reconstruction of 
cardiac anatomy. 
1.4.3  Direct techniques - non-echocardiographic methods 
1.4.3.1  Nuclear imaging 
Single positron emission computed tomography, or SPECT is a 3-
dimensional nuclear medicine technique.  It requires the injection of a 
radioactive isotope that emits gamma radiation that is detected by a camera 
that rotates around the patient.  The acquisition of data is temporally gated 
against the ECG to allow the regional onset of myocardial contraction to be 
determined42.  Although the temporal resolution is relatively low at 8 or 
16Hz, Fourier transformation of the data allows interpolation with effective 
frame rates of up to 75 Hertz.  This technique has been validated in single 
studies against 2-D and 3-D tissue Doppler echocardiography, and been 
used in patients undergoing CRT and found to correlate with response and 
have good predictive value43,44. 
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1.4.3.2  Cardiac Magnetic Resonance Imaging 
Various cardiac magnetic resonance imaging techniques have also been 
used, incorporating cine, phase contrast and tagged imaging. MRI has been 
used to predict the response to cardiac resynchronisation therapy.  A 
detailed review of these techniques is outside the scope of this thesis, but is 
covered by Pennell45.  Potential advantages of CMR based techniques 
include high spatial resolution and the fact that this is a 3-dimensional 
technique that can tag tissue characteristics to measure local strain.  
However, the disadvantages include cost, long imaging time, complex and 
long analysis times and incompatibility with implanted devices.  Although 
recently developed systems are available with MRI compatibility, CMR 
dyssynchrony has not yet been assessed in cohorts of patients with 
implanted devices. 
 
1.4.3.3  Cardiac Computed Tomography 
Cardiac CT has been studied in a single study of 38 patients.  They 
examined 3 indices of dyssynchrony - the standard deviation of the time 
from the R wave to maximal wall thickness, the standard deviation of the 
time to maximal wall motion and the standard deviation of time to minimal 
systolic area.  They also looked at segmental measures - the average of the 
maximal difference in time to max wall thickness or motion among 3 pairs 
of opposing walls.  The global indices had a reasonable reproducibility, but 
their role in the assessment of patients requires further study46.  However, 
this technique is limited as it delivers ionising radiation to patients and 
therefore carries a risk of inducing cancer.  This effectively excludes this 
technique from routine clinical use. 
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1.4.4  Direct techniques - echocardiographic methods 
1.4.4.1  Motion-mode 
Echocardiography relies on the rendering of reflected ultrasound waves 
to produce an image.  The simplest technique is that of M-mode or motion 
mode echocardiography, which uses a single point beam and displays the 
result against time.  When applied to the heart from the para-sternum, this 
allows the motion of the mitral valve and the inter-ventricular septum and 
posterior walls to be interrogated.  This allows the motion of opposing walls 
to be compared, and the difference in the time to peak systolic motion of 
those opposing walls has been used as one of the first methods of 
quantifying intra-ventricular dyssynchrony.  Although it has the benefit of 
high frame rates and therefore good temporal resolution, it is limited by the 
fact that the line of ultrasound may not be perpendicular to the radial 
motion of the ventricle which therefore can give spurious results.  This has 
been improved by technologies which allow simultaneous 2-D imaging to 
help alignment, as well as angle correction.  It is also limited in that this 
measure only interrogates the inter-ventricular septum and posterior walls. 
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Figure 1.1 Image demonstrating septal to posterior wall motion delay.  It is the 
interval between maximal posterior and septal displacement of left posterior 
and septal wall using a mono-dimensional short-axis view at the papillary muscle 
level. Intraventricular dyssynchrony is defined by a septal-to-posterior wall 
motion delay of .130 ms.  Reproduced from Schmidt et al.47 
 
 
1.4.4.2  Doppler imaging 
Doppler imaging relies on the movement of myocardium or blood to 
alter the frequency of the reflected sound wave.  The amount of the the 
Doppler shift is proportional to the velocity, and therefore this imaging 
mode allows the quantification of velocity of both blood flow or 
myocardium.  The application of Doppler imaging to myocardial motion is 
termed tissue Doppler imaging48.  In both instances, the display can be 
either colour coded for a relatively large sample area, or concentrated on a 
small sample area which is graphically displayed against time.  Doppler 
measurements of flow can be used as an estimate of pressure and as a 
surrogate of cardiac output - both of which can be used as indirect 
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measures of dyssynchrony.  Also, rather than simply quantifying flow, 
Doppler measurements can be used to compare timing, for example, to 
calculate the difference in time to onset of right and left ventricular flow as 
an index of inter-ventricular dyssynchrony.  A measurement known as the 
myocardial performance index, or Tei-index has also been proposed as a 
global measure of cardiac function which is calculated as the ratio of 
isovolumic times to ejection time49.  Furthermore, the onset of left 
ventricular ejection has also been proposed as a global marker for intra-
ventricular dyssynchrony.   
Figure 1.2  Illustration of Myocardial Performance Index, or Tei-index.50 
 
Doppler measurements can also be made of the myocardial tissue.  The 
timing of tissue Doppler measurements of myocardial motion can be 
employed to get a more comprehensive assessment of segmental motion.  
Differences between 2 segments, or the maximum difference between 3 
pairs of opposing segments can be calculated.  The standard deviation of 
the time to peak velocity of the 12 basal and mid segments as interrogated 
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from the left ventricular apex, also known as the Yu index, is the epitome of 
this technique. 
Figure 1.3.  Regional myocardial velocity curves obtained by tissue Doppler 
imaging at the basal septal (yellow) and basal lateral (green) segments. In the 
color 2D pictures, movement of the myocardium toward the probe (during 
contraction) is shown in red, whereas movement away from the probe (during 
relaxation) is shown in blue. Panel A, In a patient with LBBB, there was delay in 
the onset and peak sustained systolic contraction (SM) in the lateral compared 
with the septal wall. Regional contraction occurred in a haphazard manner in 
various segments as illustrated by the patchy areas of blue colors (arrowheads). 
Panel B, After biventricular pacing, there was dramatic improvement in the 
synchronicity, as reflected by the overlapping of velocity curves in the basal 
septal and basal lateral segments and the homogenous red color in the two-
dimensional picture.51  
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Doppler measurements of flow and of myocardial velocity also have the 
advantage of high temporal resolution, but are significantly angle 
dependent which may impact on their reproducibility. 
1.4.4.3  Two and Three dimensional imaging 
Two dimensional imaging requires the ultrasound beam to sweep along 
a line, whereas 3 dimensional imaging requires the ultrasound beam to 
move in two orthogonal directions.  To allow time for emission and 
receiving of ultrasound signals as well as motion of the ultrasound beam, 
the temporal resolution of the resulting images is diminished.  The advent of 
matrix transducers has enabled the use of multiple ultrasound emitters and 
receivers and thus increased the temporal resolution of these methods, but 
nevertheless 3-dimensional imaging has a lower temporal resolution than 2-
dimensional imaging, which again has a lower temporal resolution than 1-
dimensional imaging such as M-mode.  Live 3D volumes often have 
volume rates of 20Hz or so, though parallel processing can allow over 60 
volumes per second.  In patients who have a heart rate above 60 beats per 
minute, the number of volumes per heart cycle falls further.  Acquiring 
multiple heart cycles with ECG gating increases the temporal and spatial 
resolution, but at a cost of stitching artefacts that arise because of variability 
in heart rate as well as respiratory motion of the heart. Despite the lower 
temporal resolution, the addition of extra dimensions decreases the need for 
mental reconstruction of constituent images, and allows the exact 
relationship of lines or planes through the heart to be determined.  
Two dimensional and 3 dimensional imaging can be used to 
qualitatively describe the motion of the left ventricle.  Quantification of 
intra-ventricular dyssynchrony has focussed on the differences in time to 
peak displacement or strain.  This can be calculated for an absolute 
difference between two segments, the maximum difference between 3 pairs 
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of opposing segments, or the standard deviation of a number of segments - 
6 basal, 12 mid and basal segments or 16 or 17 segments for the entire left 
ventricle depending on the segmentation model used.   
Whilst measuring the magnitude of displacement is a simple concept, 
that of strain is more complex.  Strain is the quantity that reflects change in 
length - when applied to echocardiography two points are chosen and the 
difference in length between those points between diastole and systole is 
the strain.  It has a directional component to it, and in 2-dimensional 
echocardiography the directions considered are longitudinal, 
circumferential or rotational and radial.  It may be derived from tissue 
Doppler imaging as the integral of the velocities that Doppler imaging 
directly measures, or more recently by speckle tracking. 
When looking at a rendered echocardiographic image, a pattern of 
speckles is obvious within the myocardial tissue.  These arise due to tissue 
features smaller than the wavelength of the ultrasound resulting in 
constructive and destructive interference in the reflected sound waves.  The 
pattern of speckles is therefore characteristic of the myocardial tissue and 
the pattern can be tracked from frame to frame throughout the cardiac cycle 
and therefore allow tissue motion to be characterised.  This is angle 
independent and allows the calculation of velocities and strain52.  The 
velocity of the myocardium is an obvious target to measure, but strain is a 
relatively novel concept in echocardiography. 
Speckle tracking derived strain is an attractive parameter because it is 
not angle dependent and measures tissue contraction rather than 
displacement which may occur passively for example when a scarred non-
contractile segment is pulled on by neighbouring contractile segments. 
 Although modern techniques can assess motion or strain for hundreds 
or thousands of segments of myocardium, most techniques involve 
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amalgamating the data from these smaller segments into the 16 or 17 larger 
segments as used in clinical practice. 
Disadvantages of speckle tracking are that it requires a high frame rate 
and extremely good image quality of the whole myocardium throughout the 
cardiac cycle.  It is a summative approach - i.e. current techniques do not 
have the resolution to track the individual layers of the myocardium whose 
fibres are arranged in different directions and would therefore be expected 
to show different values.  Current approaches average values for the whole 
trans-mural segment.  Furthermore, it may be impacted on by the 
translational motion of speckles in the plane orthogonal to the echo plane. 
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Figure 1.4 Example of 3D speckle tracking derived strain.  The segments are 
demonstrated in the upper left endocardial cast, bulls-eye plot upper right, and 
individual segments plotted against time on the lower right panel.  Numerical 
results are in the lower left panel.
 
1.4.4.4  Measurement Variability 
1.4.4.4.1  Doppler and two-dimensional methods 
Any method that purports to measure dyssynchrony must be reliable and 
reproducible.  This is particularly important for those techniques that have a 
significant learning curve.  3D echocardiography requires expertise not 
only in the acquisition of datasets, but also in their analysis.   
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The PROSPECT study was a multi-centre study of 498 patients that 
investigated the utility of M-mode, pulsed Doppler and tissue Doppler 
derived indices of dyssynchrony as predictors of response to CRT53.  
Response was defined using a clinical composite score as well as a 15% or 
greater reduction in left ventricular end-systolic volume (LVESV) at 6 
months compared to baseline.  Each centre underwent training and was 
required to submit a high-quality study before patient enrolment.  The core 
laboratories had access to a written measurement manual that had been 
approved by the steering committee.  Intra-observer variability was similar 
in all core laboratories, and was low for left ventricular end systolic volume 
and left ventricular pre-ejection interval (Coefficient of Variation(CV), 3.8% 
and 3.7%, respectively).  Variability was moderate for the standard 
deviation of the time to peak systolic velocity of 12 mid and basal 
myocardial segments (Ts-SD)(CV 11.4%) and the maximum time difference 
between the peak systolic velocity of the 6 basal segments (Ts-peak) (CV 
15.8%).  There was high variability for Septal to Posterior Wall Motion 
Delay (SPWMD) (CV, 24.3%).  Inter-observer variability was higher for 
each parameter than intra-observer variability, with high variability for Ts-
peak, Ts-SD, and SPWMD (CV, 31.9%, 33.7%, and 72.1%, respectively).  
Furthermore, a significant proportion of studies were deemed not to be 
interpretable, ranging between 61% and 95% for the routine non-TDI 
methods and between 37% and 82% for TDI-based tests 
They concluded that the interpretability and variability of measurements 
accounted for the lack of sensitivity and specificity of any of these measures 
in predicting outcome from CRT. 
1.4.4.4.2  Three-dimensional methods 
Few studies have looked for intra-patient reproducibility, but one 
observer studied 15 patients within 24 hours and showed good intra-class 
correlation coefficients (ICC) and variability for end-diastolic volume (EDV), 
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left ventricular ejection fraction (LVEF), and SDI-16 were 0.99 and 1%, 0.98 
and 3.7%, and 0.88 and 4.6%, respectively54.  Soliman and others also 
performed test-retest reproducibility on 10 subjects and showed an ICC of 
0.951, and a variability of 10%55. 
Intra-observer and inter-observer reproducibility has been reported by 
most groups, with a range of intra-observer correlation coefficients for SDI-
16 between 0.86592 to 0.99614, and inter-observer correlation of between 
0.8182 and 0.99314.  Reproducibility is also better in patients with good 
quality datasets when compared to moderate quality datasets55. 
Inter-institutional variability for SDI-16 has also been reported56.  This 
group recruited 120 healthy subjects in Switzerland, and their datasets were 
analysed in both Switzerland and in Minnesota, USA.  Although the mean 
values and 95% confidence intervals of SDI-16 did not overlap, the 
concordance correlation coefficient and the limits of agreement suggested 
that there is no significant difference in the measurements between the two 
institutions. 
These publications did not include Bland-Altman plots57 as a method to 
assess reproducibility of these measurements. The statistical literature 
conflicts, with some authors suggesting intraclass correlation is the best 
measure of reliability58, whilst Bland et al suggest this is reasonable for 
validation studies only59.  
1.5  Assessment of Dyssynchrony 
1.5.1  Dyssynchrony in healthy subjects. 
Healthy subjects have been assessed by all the techniques delineated 
above.  The surface ECG demonstrates a p wave indicating atrial activity 
that lasts 80 to 110 ms.  The interval between the p wave and the onset of 
the QRS complex is termed the pr interval and is normally 120 to 200ms.  
The QRS complex is generated by ventricular depolarisation and normally 
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lasts approximately 80ms, though values over 120ms are taken to be 
abnormal.  Studies of 67,375 men in the United States Airforce have been 
used to generate normal values, and describe the frequency of variants such 
as right and left bundle branch block38,39,60. 
None of the other techniques have been used in such large populations, 
but nevertheless, normal values have been published, frequently in the 
context of comparison with patients with cardiac disease, and these 
demonstrate that the normal timing of contraction is exquisitely well 
coordinated.  A detailed review of all of these data is outside the purview of 
this thesis, but data for three-dimensional echocardiography is presented 
below. 
Normal values for dyssynchrony and ejection fraction by 3D 
echocardiography have been generated by a number of groups, with 
varying numbers and ages of patients.  The studies have varied as to those 
that have used normal volunteers, or patients referred for routine 
echocardiography that were deemed to be normal.  Four studies have 
attempted to define normal ranges in adults by taking large samples of 
healthy subjects, but most studies have used a small sample as a control 
group against whom to compare the results from their patients.  All the 
published values are summarised in table 5.2.  Only a single study has 
published data in a paediatric population61.  They examined 9 healthy 
children aged between 4.5 and 16 years old as controls to compare against 
children with LV dysfunction.  In the healthy group the median SDI-16Q 
was 2.1%.  
Kapetanakis et al studied 89 healthy adults and suggested that the upper 
limit of normal SDI-16 was 8.3% because this value was 3 standard 
deviations above the mean value of 3.5%54. 
Gimenes et al investigated 131 subjects, 73 were male and the average 
age was 46 ± 14 years62.  These subjects did not have any structural cardiac 
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abnormalities, or history of cardiac disease, but had been referred for 
routine echocardiography.  The mean SDI-16Q was 1.59 ± 0.99%.  The 
frequency distribution of SDI-16Q values are appreciably skewed to the 
left. 
Conca et al published results of their investigation of 120 healthy 
subjects in an attempt to define normal ranges for 3D SDI-16Q, as well as 
tissue Doppler and radial strain imaging56.  This study was powered to be 
able to define 90% confidence intervals around the mean value.  Although 
they investigated 120 healthy subjects, they were only able to perform 3D 
assessment in 102 patients.  They proposed a normal range for SDI-16Q of 
1% to 4.8%, based on the 97.5% confidence intervals for their population.  
Interestingly, they found that there was little concordance between the two 
centres for tissue Doppler and radial strain imaging, but significant 
concordance in SDI-16Q. 
De Castro et al studied 116 healthy volunteers and 20 elite athletes63.  
They validated their results by performing CMR on 20 of these subjects.  In 
healthy volunteers the mean SDI-16 was 2.37 ± 0.8%.  They also describe 
the pattern of contraction seen in these subjects.  The apex appears the 
most synchronous, and contracts earliest, whilst the basal segments are 
slightly less synchronous and contract later.  Thus they describe a 
contraction time gradient from apex to base. 
While the normal ranges for any test should be determined locally, most 
studies agree that the normal value of SDI-16 is approximately 3%, and that 
most healthy individuals have values below 6%.  There do not appear to be 
significant differences in the normal range dependent upon the software 
used to generate SDI-16.  There is an overlap between this normal range 
and the values seen in mild left ventricular dysfunction.  However, values 
in the context of cardiac disease are discussed below. 
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1.5.2  Dyssynchrony due to right ventricular pacing. 
Dyssynchrony due to right ventricular pacing has been investigated for 
nearly as long as pacing therapy has existed.  As pacing developed in the 
1960’s there was interest in the effects of pacing at different ventricular 
sites, but these early studies did not demonstrate significant differences at 
different sites and the right ventricular apex came to be the preferred site for 
ventricular pacing.  In the 1980’s interest in atrio-ventricular synchrony was 
generated by the advent of pacemakers that were capable of tracking atrial 
activity and thereby eliminate atrio-ventricular dissociation.  From the 
1990’s onwards, attention was again focussed on intra-ventricular 
dyssynchrony as randomised controlled trials failed to demonstrate the 
expected benefits from dual chamber pacing and as bi-ventricular pacing 
was developed.  These studies will be further explored below. 
1.5.2.1  Atrioventricular dyssynchrony 
Complete atrioventricular dyssynchrony exists in complete heart block 
and this remains a feature in single chamber ventricular pacing.  This can 
cause overt symptoms, which were first described in 1969 as pacemaker 
syndrome9.  The ability to artificially synchronise atrial and ventricular 
pacing with a dual chamber pacemaker system allowed the investigation of 
the relative contribution of atrial contraction to cardiac output.  Samet and 
others demonstrated that the atrial contribution to filling was greater than 
the effect of abnormal depolarisation caused by ventricular pacing, and 
indeed atrial sequential ventricular pacing did have a small detrimental 
effect on haemodynamics compared to intrinsic rhythm, but they suggested 
this might be explained by the shorter pr interval required to obviate 
intrinsic conduction64,65.  A clinical correlate to this was a case report by 
Haas and others that described a severe case of pacemaker syndrome with 
falls in cardiac output seen with VVI pacing66.  Comparison with single 
chamber pacing has demonstrated higher left ventricular end-diastolic 
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pressures, higher systolic and mean blood pressure, and lower right atrial 
and pulmonary capillary wedge pressures, as well as an increase in cardiac 
output with AV sequential pacing10. 
1.5.2.2  Intra-ventricular dyssynchrony, and the effect of pacing at 
different right ventricular sites. 
The first report of endocardial pacing by Furman and others included 
pacing at both the right ventricular apex and the right ventricular outflow 
tract7.  In the subsequent decade there was a great deal of interest in 
determining the best place to pace the heart.  Most studies were done in 
dogs, with conflicting results.  Barold and others investigated 52 patients 
and paced both the RV inflow and outflow tract67.  The inflow tract was 
defined as being just lateral to the spine, so therefore is similar to the 
position that would be termed the apex today.  They found no significant 
differences in mean pulmonary or systemic pressures or in cardiac index 
when pacing at these locations. 
One of the first studies using echocardiography to evaluate the effects of 
pacing at different RV sites was reported in 197468.  Abassi and others used 
M-mode echocardiography in patients with left bundle branch block as 
well as patients during right ventricular apical pacing.  They found in left 
bundle branch block there was an early pre-ejection posterior motion of the 
inter-ventricular septum, together with paradoxical anterior motion during 
systole.  During pacing, 7 of 10 patients exhibited a similar pattern of 
motion as those with left bundle branch block, 3 had apparently normal 
septal motion.  These findings were expanded upon by Gomes and others 
who investigated patients with right ventricular pacing at the apex, outflow 
tract and inflow tract69.  They selected patients because they had normal 
motion of the inter-ventricular septum in intrinsic rhythm.  Pacing the inter-
ventricular septum resulted in a biphasic motion with pre-ejection posterior 
motion of the IVS and then either anterior or posterior motion during the 
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ejection period.  They found that pacing at inflow and outflow tracts 
resulted in abnormal motion in all patients, but during apical pacing there 
were a minority of patients that had normal septal motion.  Furthermore 
they noted a delay between the septal motion and the posterior motion.  
Interestingly, in all locations, pacing resulted in a fall in end-diastolic 
dimensions, but not end-systolic dimensions, and this effect was seen with 
pacing in all sites.  
Over the intervening 30 years these findings have been built on as 
newer echocardiography techniques have been developed.  Xiao and 
others investigated 24 patients with RV apical pacing and 24 with left 
bundle branch block, with M-mode and Doppler echocardiography70.  As 
in previous studies, they noted pre-ejection systolic motion of the inter-
ventricular septum more frequently in left bundle branch block than during 
RV apical pacing.  They also found that the isovolumic times were longer in 
LBBB than during RV pacing.  They concluded that RV apical pacing was 
not a good experimental model for left bundle branch bloc. 
Other modalities have been used to quantify the effects of pacing on left 
ventricular function.  Leclerq and others performed haemodynamic and 
radionuclide studies on patients with normal intrinsic conduction and 
tested various pacing modes, including AAI, DDD and VVI71.  They 
demonstrated that AAI pacing was better than the other 2 modalities in 
terms of cardiac output, pulmonary capillary wedge pressure, right atrial 
pressure, pulmonary artery pressure, LV stroke work index and LV ejection 
fraction.  The differences were mainly due to the negative effects of right 
ventricular pacing on septal ejection fraction and on LV filling. 
Schwaab and others also used this methodology to compare pacing the 
RV apex with pacing the RV septum72.  They optimised the septal position 
of the electrode by assessing which position gave the narrowest paced QRS 
complex duration on the surface ECG.  They also optimised the AV delay 
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for both positions.  Again, by using radionuclide ventriculography they 
demonstrated that the decreased QRS duration associated with septal 
pacing correlates both with more synchronous left ventricular contraction 
and better systolic function. 
Victor and others performed one of the first clinical trials of septal 
pacing73.  In an elegantly designed clinical study they placed dual chamber 
pacemakers in 16 patients with atrial fibrillation who had undergone AV 
node ablation to induce complete heart bloc.  Rather than using the atrial 
channel of the pacemaker for an atrial lead, they placed both leads in the 
right ventricle, one in the apex and the other in the right ventricular outflow 
tract.  The patients were enrolled in a randomised cross-over protocol with 
pacing at the RVOT or apex for 3 months at a time.  At the end of each 
period, they assessed NYHA class, left ventricular ejection fraction using 
radionuclide angiography, exercise time and maximal oxygen uptake.  They 
did not demonstrate significant differences in any of these parameters, nor 
did they see any differences when the patients were stratified into 2 
subgroups using a cut-off of a baseline ejection fraction of 40%.  A similar 
study by Mera and others placed the leads in the RV apex or septum74.  
They found that septal pacing produced a shorter QRS duration and 
although it didn’t lead to significant differences in LV dimensions as 
assessed by M-mode echocardiography, it did lead to a high fractional 
shortening, and a higher ejection fraction at rest measured by radionuclide 
angiography.  
An invasive haemodynamic study by Kolettis and others showed no 
differences in systolic function between apical and RVOT pacing, but better 
indices of diastolic function with RVOT pacing75. 
Deshmukh et al investigated His-bundle pacing after AV node ablation 
for permanent atrial fibrillation and dilated cardiomyopathy76.  This 
population had a low mean ejection fraction at baseline of 20%.  His-
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bundle pacing was feasible in only 14 out of 18 patients, correct location of 
the pacing lead was challenging, and the mean threshold was relatively 
high at 2.4V at a 0.5ms pulse width.  Nevertheless, echocardiographic 
improvement in heart function was demonstrated by a fall in left ventricular 
dimensions and an increase in fractional shortening at long term follow up.  
In contrast, Szili-Torok and others found that apical pacing in a similar 
cohort of patients with slightly better baseline ejection fraction (mean 
47.5%) did not lead to any change in  ventricular dimensions, but there was 
a significant fall in left ventricular ejection fraction to 43.2% at 3 months77. 
Tantengco evaluated young patients with mostly congenital or acquired 
complete AV block, normal left ventricular morphology and function and 
no intracardiac shunts.  After an average of 9.5 years of RV apical pacing, 
these patients had impaired 2D and Doppler echocardiographic measures 
of LV function when compared to normal controls78. 
Tse and others provided evidence that longer-term remodelling resulted 
in adverse effects with RV apical pacing.  They randomised 30 patients with 
complete heart block to apical or RVOT locations.  The mean ejection 
fraction was 59% at baseline echocardiography.  At 6 and 18 months the 
patients underwent dypridamole stress thallium myocardial scintigraphy 
scans.  RV apical pacing resulted in a broader QRS duration of 151ms vs 
134 ms, and at 6 months there was a trend to increased myocardial 
perfusion defects and regional wall motion abnormalities but similar 
ejection fraction with apical pacing.  By 18 months, the trend had become 
statistically significant and furthermore there was a significant fall in LV 
ejection fraction with pacing (47% vs 56%). 
Nielsen and others investigated 177 patients with AAIR and DDDR 
pacing and followed them for a mean of 2.9 years79.  Interestingly, they 
found that good echocardiographic follow up was challenging, with good 
quality paired apical 2 and 4 chamber views available in only 50 to 60% of 
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patients.  Nevertheless, DDDR pacing led to an increase in left atrial 
dimensions whilst AAI pacing did not.  Confirming the MOST findings, in 
those patients with a high proportion of right ventricular pacing there was a 
reduction in left ventricular ejection fraction. 
The ROVA trial was a crossover trial of RVOT versus RV apical pacing 
in patients with heart failure, permanent atrial fibrillation and standard 
bradycardia indications for permanent pacemaker therapy80.  They found 
that RVOT pacing shorten the QRS duration but after 3 months did not 
improve quality of life score, and indeed LVEF as assessed by 2D 
echocardiography was higher in the group assigned to apical pacing rather 
than RVOT pacing. 
Nahlawi and others demonstrated using serial gated blood pool studies, 
that RV apical pacing results in deleterious effects on ejection fraction that 
persisted for at least 24 hours81. 
Thambo and others show that dyssynchrony as measured by tissue 
Doppler calculation of delay longitudinal contraction is higher in patients 
who’ve been paced for a mean of 10 years for congenital complete heart 
block than in normal controls.  Also, LV end diastolic dimension was higher 
and they had a lower cardiac output and exercise performance82. 
A single study has used 3D echocardiography to evaluate dyssynchrony 
in 35 patients with sick sinus syndrome who had had dual chamber 
pacemakers implanted in the last 3 to 128 months83.  They performed 
echocardiography when pacing the atrium, with intrinsic conduction, and 
when dual chamber pacing.  With intrinsic conduction, the mean QRS 
duration was 90ms ± 14ms, not significantly different from control patients.  
The ventricular lead was in the RV apex. They measured myocardial 
performance index, tissue Doppler imaging of 12 segments, and 3D 
echocardiography SDI-17. 
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The myocardial performance index was significantly worse with apical 
pacing (with pacing 0.42 ± 0.18 vs. without pacing 0.31 ± 0.14; p= 0.004), 
and LVEF derived by 3D echocardiography was significantly lower with 
apical pacing (with pacing 54.4% ± 7.7% vs. without pacing 56.7 ± 7.9%; 
p= 0.013), indicating a deterioration of left ventricular function with apical 
pacing. The mean change in LVEF with apical pacing in an individual 
patient was 4.1%.  There was also more dyssynchrony associated with 
apical pacing (SDI-17 with pacing 7.00% ± 2.54% vs. without pacing 
5.36% ± 2.17%; p= 0.0003). Thus, RVA pacing induced 30.6% change in 
SDI-17 from baseline without RVA pacing. 
However, the total pacing burden, or pacemaker programming of these 
patients is unknown, so it is unclear if there had been any chronic pacing 
induced change in left ventricular mechanics after implantation but before 
echocardiographic examination. 
In summary therefore, these studies have demonstrated the deleterious 
effects of right ventricular apical pacing on global parameters of cardiac 
function and have suggested that this occurs due to increased 
intraventricular dyssynchrony.  There is less data in the pacing of alternative 
right ventricular sites and these alternative sites include the His bundle, 
right ventricular outflow tract and right ventricular septum.  These data are 
suggestive that alternative sites offer better ventricular function than right 
ventricular apical pacing, but there is conflicting evidence and insufficient 
data overall to draw a firm conclusion. 
1.5.3  Dyssynchrony in left bundle branch block 
The investigation of left bundle branch block is potentially confounded 
by the fact that it is a very rare finding in patients without structural heart 
disease.  Therefore most studies have necessarily involved patients with 
concomitant heart disease, though these have usually been compared to 
patients with heart failure and a normal QRS complex as well as normal 
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patients.  Initially the focus was on the characteristics of left bundle branch 
block, but as CRT developed as a treatment, a great deal of interest was 
focussed on the assessment of dyssynchrony and the role that this could 
play in patient selection. 
1.5.3.1  Electrical mapping of left bundle branch block 
In 1984, endocardial electrical mapping of patients with left bundle 
branch block was reported84 in 18 patients, 3 of whom had no other 
evidence of cardiac disease and were not on anti-arrhythmic medication.  
The other 15 were a heterogeneous group comprising patients with 
ischaemic heart disease, valvular disease or cardiomyopathies.  The study 
was performed by placing intra-cardiac catheter electrodes and recording 
electrograms at multiple different points.  This study demonstrated that left 
bundle branch block led to delayed activation of the left ventricle 
compared to the right ventricle, that the left ventricle was activated by right 
to left transeptal activation, and that the left ventricular endocardial 
activation sequence is heterogeneous amongst patients with different 
pathologies as the aetiology of left bundle branch block.  Indeed later work 
with 3 dimensional electrical endocardial mapping has demonstrated that 
septal activation may also occur due to delayed conduction through the left 
bundle, rather than right to left trans-septal activation85.  Right ventricular 
pacing has also been investigated using this technique which has 
demonstrated similar prolongation of timing of left ventricular activation as 
in left bundle branch block, but that the pattern of activation was markedly 
influenced by the site of previous myocardial infarction86. 
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1.5.3.2  Echocardiographic assessment of left bundle branch block and 
its utility in CRT 
1.5.3.2.1  M-mode and 2D echocardiographic assessment 
Visual interpretation of 2D loops is perhaps the simplest method, and 
the abnormalities seen in left bundle branch block include multi-phasic 
motion of the inter-ventricular septum, rocking of the left ventricular apex 
and delay of the posterolateral wall.  Unfortunately, these changes can be 
subtle87 and the diagnostic specificity for dyssynchrony on one study was 
only moderate when compared with tissue Doppler imaging88. 
1.5.3.2.2  Doppler assessment 
Tissue Doppler imaging is attractive because of the very high temporal 
resolution.  A number of parameters have been developed, from calculating 
the delay between the septum and the lateral wall in the 4 chamber apical 
view to more comprehensive assessments looking at the mid and basal 
segments of each wall in the 2, 3 and 4 chamber views.  The standard 
deviation of the time to peak velocity in these 12 segments has become 
known as the Yu index89.  These tissue Doppler assessments are highly 
angle dependent and whilst these indices have shown promise in single 
centre studies, Prospect, a multi-centre prospective trial looking at echo 
parameters as predictors of outcome from CRT failed to demonstrate good 
predictive ability.  This was ascribed to relatively low yield and high 
variability in the tissue Doppler measures53. 
The interest in Doppler assessments of dyssynchrony led to the 
investigation of patients with heart failure and without left bundle branch 
block.  In a number of trials it has been demonstrated that QRS duration 
correlates poorly with dyssynchrony90,91, that dyssynchrony exists in 
patients with a normal QRS duration92 and single and dual centre studies 
suggested benefit from CRT in patients without a prolonged QRS duration 
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but with Doppler evidence of dyssynchrony93,94.  However, a multi-centre 
prospective study has failed to show beneficial effects of CRT on this 
population95, with other multi-centre trials in progress.  How are these 
conflicting findings explained?  Firstly, in studies looking at the correlation 
between QRS duration and dyssynchrony, the pattern of the QRS complex 
was not considered.  It is likely that right and left bundle branch block or 
non-specific intraventricular conduction delay have differential effects on 
mechanical dyssynchrony.  Furthermore, the variability in tissue Doppler 
measures may mean that in expert hands and single centre studies it is 
useful, but this doesn’t translate into wider applicability.  Finally, there is 
some evidence that the effect of CRT is not wholly mediated by 
dyssynchrony, but rather the amelioration of pericardial constraint on the 
left ventricle.  Two studies from the same group have demonstrated acute 
haemodynamic benefits from CRT in patients with narrow QRS and no 
dyssynchrony on echocardiography, 96 and in patients with narrow QRS 
with no selection by echocardiography, longer term improvements in 6 
minute hall walk distance, quality of life scores and New York Heart 
Association class. 
1.5.3.2.3  Speckle tracking 
Speckle tracking has also been used to assess dyssynchrony.  Suffoletto 
and others demonstrated that this had good sensitivity and specificity to 
predict long term left ventricular remodelling after CRT97.  They measured 
the time difference in peak septal wall to posterior wall radial strain on the 
basis that the computer algorithm appeared to track more reliably images 
from the parasternal short axis than apical acquisitions and the recognised 
effects of bundle branch block on septal motion.  Interestingly, they did not 
find any significant differences in the measurements made using speckle 
tracking and using tissue Doppler to calculate radial strain.  This group has 
subsequently prospectively demonstrated the value of speckle tracking 
dyssynchrony assessment in assessing CRT response, particularly with 
  48 
regard to patients without broad left bundle branch block98.  Other authors 
have confirmed this finding99, but have also demonstrated that other strain 
derived parameters such as longitudinal and circumferential strain appear 
to be less powerful as a predictor of response to CRT99-101.  Further 
parameters have been investigated which include the standard deviation of 
the time to peak radial strain of the 6 segments in the mid ventricular short 
axis view, the standard deviation of time to peak longitudinal strain of the 
12 basal and mid segments from the apical view, the strain delay index 
which was defined as the sum for 16 segments of the difference between 
longitudinal peak and end-systolic strain.  Yet others have looked at LV 
twist and torsion at aortic valve closure, global longitudinal strain and holo-
systolic shortening. 
1.5.3.2.4  3D echocardiography 
The studies in this area have focused on several heterogeneous groups of 
patients.  These include patients with any form of cardiovascular disease, 
patients with heart failure and impaired ejection fraction, patients with left 
bundle branch block (LBBB) with and without symptoms, and patients who 
are candidates for cardiac resynchronisation therapy (CRT).  The goal has 
been to describe the distribution of dyssynchrony in disease, as well as to 
see if 3D measures of dyssynchrony can help to better select patients who 
might benefit from CRT than the QRS duration alone. 
Most groups that have looked at patients with cardiovascular disease 
and a range of cardiac function have demonstrated a strong negative 
correlation between ejection fraction and SDI-16 54,102-104.  This is illustrated 
in figure 5.10. 
However, this correlation may be weaker in patients with drug-
refractory symptomatic heart failure.  In 40 patients referred to a heart 
failure clinic there was no significant difference in SDI-16 between patients 
with an EF < 30% (6.9 ± 3%) as compared to patients with an EF > 30% 
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(8.8 ± 6.3%)105.  The QRS width may be a confounding factor in this study 
as this cohort contained patients with both narrow and broad QRS and the 
distribution of broad QRS is unclear between the two groups with EF >30% 
and EF <30%. 
It is difficult to separate dyssynchrony induced by LBBB alone with that 
seen in impaired left ventricular function, especially as LBBB is rare in 
healthy individuals.  One group addressed this question by analysing the 
difference in dyssynchrony indices between healthy subjects, asymptomatic 
subjects with LBBB, and patients with heart failure and LBBB106.  In the 
healthy subjects, mean LVEF was 54 ± 5% and SDI-16 was 5.6 ± 3.6%, in 
patients with asymptomatic LBBB the LVEF was 50 ± 9%, and SDI-16 7.3 ± 
3.2% and in heart failure patients with LBBB the LVEF was 29 ± 9% and 
SDI-16 12.8 ± 4.8%.  SDI-16 was significantly higher in HF patients than 
both other groups, but although the mean SDI-16 in subjects with 
asymptomatic LBBB was higher than healthy subjects, this difference did 
not reach statistical significance (p=0.08).   Also the mean QRS duration in 
the asymptomatic LBBB group was less than that of patients with HF and 
LBBB, this also did not quite reach statistical significance (p= 0.052).  This 
suggests there may be a correlation between QRS width and SDI-16. 
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However, another study found this correlation between QRS width and 
SDI-16 in patients with heart failure to be weak.  Soliman and others 
studied 84 patients with heart failure and either a narrow (mean QRS 98 ± 
12ms, 30 patients) or wide QRS (mean QRS 157 ± 26ms, 54 patients) 55. 
The SDI-16Q was significantly larger in the wide QRS group (15.0 ± 7.9%) 
than in the narrow QRS group (10.5 ± 7.7%, p< 0.01).  The correlation 
between the QRS duration and the SDI-16 was weak (r2 = 0.07, p< 0.05), 
as was the correlation between the SDI-16 and the LVEF (r2 = 0.12, p< 
0.01).  Out of this cohort 20% of the patients with HF with LVEF less than 
35% had a narrow QRS and high SDI-16, and 14% of the patients with HF 
with LVEF greater than 35% had narrow QRS and high SDI-16.  This is 
illustrated in figure 5.11. 
1.5.3.2.4.1  Patterns of dyssynchrony 
3D echocardiography has revealed some insights into the pattern of 
dyssynchrony in in patients with left ventricular dysfunction.  A 
comparative study of tissue Doppler and 3D dyssynchrony found that 3D 
echo was less sensitive than tissue Doppler at detecting significant 
dyssynchrony, and that the areas of maximum delay varied by tissue 
Doppler and 3D echo103.  By 3D echo, the anteroseptal and septal walls 
were more frequently the most delayed, whilst by tissue Doppler it was the 
lateral and posterior walls  This is illustrated in figure 5.7, in which the 
lower left panel shows contraction front mapping and the septal wall to be 
red indicating delayed contraction.  This variation occurred even in patients 
deemed to have good images.  When 3D echo and TDI assessment of 
maximal delay was compared to delay by anatomical M-mode, the 
correlation was higher with 3D than TDI.   In this population of patients, 
the average ejection fraction was 37% by 2D echo and average SDI-12 was 
8.3%. 
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Furthermore, De Castro and others studied 39 patients with left 
ventricular dysfunction and narrow QRS (24 ischaemic heart disease, 15 
DCM), and 90 patients with left ventricular dysfunction and LBBB63.  They 
found that patients with left ventricular dysfunction had more dyssynchrony 
than normal and that patients with LBBB were more dyssynchronous than 
those with narrow QRS.  The pattern of contraction also differed between 
the groups, with a time gradient from apical to basal contraction in patients 
with narrow QRS, but not in patients with LBBB in whom the mid segment 
often contracted before the apical segments.  This emphasises the 
importance of assessing apical contraction and dyssynchrony, as many 
methods such as tissue Doppler imaging do not interrogate the apex. It is 
also important to realise that some 3D analysis software excludes the apical 
cap in their 16-segment model, though it still appears to have useful 
predictive value. 
1.5.3.2.4.2  SDI as a predictor of outcome of Cardiac Resynchronisation Therapy. 
CRT is a useful therapy in some patients with heart failure but it is 
acknowledged that up to a third of patients who meet current criteria for 
CRT implantation do not improve symptomatically107.  A variety of 
techniques have been assessed to see if they can better predict outcome 
than current conventional criteria53.  Several small studies with 3D 
echocardiography have shown that patients with high SDI-16 values do 
better with CRT than their counterparts with lower SDI-16.  These studies 
have mainly used echocardiographic improvements in LV function as their 
endpoints. 
Kapetanakis and others studied 26 patients who fulfilled standard criteria 
for cardiac resynchronisation therapy54.  These patients had 3D 
echocardiography performed before and 10 months after CRT implantation.  
Clinical responders differed significantly in SDI-16 but not LVEF before 
implantation, with higher SDI-16 (16.6 ± 1.1% versus 7.1 ± 2%; p=0.0005) 
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but similar LVEF (18.6 ± 2.8% versus 23.9 ± 2.4%; p=0.4) and NYHA class 
(3.4 ± 1.8 versus 3.0 ± 1.7; p=0.09). 
Delgado and others studied 27 patients with DCM scheduled for CRT 
and performed echocardiography before, 24-48 hours after, and at 6 
months108. Twenty-two patients had datasets that were adequate for 
analysis, and 11 patients were followed up at 6 months.  The most delayed 
segment was the basal and mid inferoposterior segments.  Pre CRT EF was 
26% ± 8%, SDI-16 was 14.3% ± 7.5%, immediately post CRT EF was 32% 
± 7%, SDI-16 was 9.7 ± 6.8%, at 6 months EF 39% ± 14%, SDI-16 4.9% ± 
3.1%.  These improvements were statistically significant.  They found that 
responders (as defined by a >10% decrease in end-systolic volume) to CRT 
had a higher initial SDI-16 than non-responders but in their small cohort 
this was not statistically significant. 
Marsan and others investigated 60 patients meeting standard criteria for 
CRT109.  They performed 3D echocardiography before and within 48 hours 
of CRT and calculated the SDI-16.  They excluded dyskinetic segments 
from their analysis.  All patients were in sinus rhythm and most patients 
were in NYHA class III; 62% of patients had ischaemic cardiomyopathy.  
3D echocardiography revealed severe LV dilation (mean LVEDV 201 ± 48 
mL), with depressed LV function (mean LVEF 28 ± 6%).  The SDI-16 was 
significantly higher in responders, as compared with non-responders (9.7 ± 
4.1% vs. 3.4 ± 1.8%, p < 0.0001).  Moreover, responders demonstrated a 
significant reduction in SDI-16 immediately after CRT (from 9.7 ± 4.1% to 
3.6 ± 1.8%, p < 0.0001), whereas in non-responders SDI-16 remained 
unchanged (from 3.4 ± 1.8% to 3.1 ± 1.1%, p=NS).  In addition, the 
posterolateral region (where the LV pacing lead is positioned) was latest 
activated in 74% of responders, as compared with 33% of non-responders 
(p = NS).  They performed receiver-operator characteristic to define a cut-
off value of 5.6% for SDI-16Q, which had a sensitivity of 88% with a 
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specificity of 86% to predict an acute reduction >15% of LVESV (area 
under the curve = 0.96, 95% CI = 0.9–1.0, p < 0.0001). 
Van Dijk and others performed an acute study involving 17 patients who 
had severely impaired left ventricular function and NYHA class III or IV 
heart failure, but did not necessarily have a prolonged QRS duration110.  
They investigated the utility of baseline SDI-17 to predict change in LV 
dp/dt due to biventricular pacing.  They measured LV dp/dt invasively 
during intrinsic rhythm, and after sequentially pacing the RA appendage, 
posterolateral branch of the coronary sinus and RV apex at a fixed AV delay 
of 100ms to ensure no intrinsic conduction.  The mean SDI-17 was 10.8 ± 
4.5%.  They found that SDI-17 correlated better with change in LV dp/dt 
than QRS duration. 
Soliman and others studied 39 patients (age 61 ± 12 years, 72% were 
male) with heart failure with LVEF <35%, QRS duration >120ms and on 
optimal medical therapy who underwent CRT55.  At 12 months after CRT, 
27 patients (69%) had more than 15% reduction in LVESV. These 27 
volumetric responders had similar baseline characteristics except for a 
higher SDI-16 compared with non-responders (16.3% ± 3.3% vs. 8.8% ± 
2.9%, p < 0.001). The SDI-16 was significantly improved in CRT 
responders, reaching almost normal values (7.7% ± 2.4%, p < 0.001).  
Conversely, the SDI-16 worsened in non-responders (8.8% ± 2.9% to 
11.7% ± 3.8%, p < 0.01). On the receiver operating characteristic curve, a 
value of SDI-16 greater than 10% best predicted reverse LV remodelling 
after 12 months of CRT with a sensitivity of 93%, a specificity of 91%, and 
an area under the curve of 0.91. 
The same group confirmed these findings in a similar cohort of 90 
patients undergoing CRT111.  After 12 months of CRT, 68 patients (76%) 
were responders.  Responders had larger differences in LVEDV (-21 ± 7% 
vs. -11 ± 18%, p < 0.003) LVESV (-33 ± 8% vs. -12 ± 25%, p <0.001), LVEF 
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(43 ±13% vs. 5 ± 9%, p <0.001), and 6-minute walking distance (40 ± 31% 
vs. 4 ± 22%, p <0.001) compared with non-responders.  An SDI-16Q 
>10% predicted CRT response with good sensitivity (96%) and specificity 
(88%). 
More recently Kapetanakis and others reported data on 187 patients 
from two centres who underwent CRT112.  They found excellent inter-
institutional agreement in 3D assessment of left ventricular end-diastolic, 
end-systolic volumes, ejection fraction and SDI-16, with a variability of 
2.9%, 1%, 7.1%, and 7.6%, respectively.  SDI-16 had better predictive 
ability than QRS duration for symptomatic and echocardiographic outcome 
measures, and they suggested that a SDI-16 cutoff of 10.4% had the highest 
accuracy in predicting improvement following CRT. 
These findings together suggest that SDI-16 may be a useful predictor of 
symptomatic benefit from CRT, that SDI-16 is a better predictor than QRS 
duration in determining acute response to CRT and long-term clinical 
outcomes.  The cut-off value has varied between studies, and between 
software used to determine CRT, but further studies are warranted to 
confirm these findings in larger cohorts. 
1.5.3.2.4.3  3D assessment of dyssynchrony after CRT 
Porciani et al investigated 20 patients with CRT113.  These patients had 
been implanted with an St Jude CRT device that was capable of optimising 
the delivery of CRT using an algorithm based upon intracardiac electrogram 
recordings.  The patients underwent 3D echocardiography before and after 
optimisation, using this method to assess dyssynchrony at a mean interval 
of 9 months after device implantation.  After optimisation, SDI-16 and SDI-
12 significantly decreased from 8.1 ± 4.9% to 4.2 ± 4.0% (p< 0.001) and 
from 6.0 ± 5.7% to 3.0 ± 3.7% (p= 0.01) respectively, while SDI-6 did not 
show significant change.  This improvement in LV synchrony was 
associated with improved LV systolic function as indicated by the 
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significant change in stroke volume from 56 ±16 mL to 64 ± 18 mL (p= 
0.01), and EF from 29.3 ± 11.1% to 32.3 ± 10.9% (p< 0.001).  EF improved 
in all but two patients; the mean increase was 3.0% from 29.3% to 32.3%.  
Stroke volume improved in all but 2 patients; the mean increase was 8 mL.  
Somewhat surprisingly, given the improvements in stroke volume and EF, 
there were no significant changes in EDV or ESV. 
Another factor in the delivery of CRT lies in the interplay between the 
latest contracting segment and left ventricular lead position.  3D 
echocardiography can demonstrate which segment contracts latest.  It is not 
yet clear if this is useful information, but a study by Becker et al suggests 
that when the LV pacing site is close to the latest contracting segment, then 
a patient is more likely to benefit from CRT101.  They demonstrated this by 
investigating 58 patients undergoing CRT and performed baseline 
echocardiography, and repeated echocardiography within a week and at 12 
months after CRT.  They determined the latest segment to reach minimum 
systolic volume (segment A), and they also determined the segment with the 
largest temporal difference between pre and postoperative minimum 
systolic volume (segment B).  They suggest that segment B was where the 
LV lead tip was placed, and this did correlate well with lead position as 
determined by fluoroscopy.  In those patients in whom segment B and 
segment A were the same or in close proximity (optimal patients), the 
outcome from CRT was better than when these segments were widely 
separated (non-optimal patients).  Their outcome measures were 
echocardiographic volumes, ejection fraction and that of peak oxygen 
consumption on bicycle exercise which was performed at baseline and 
after 12 months. 
For example the improvement in EF in optimal patients was 10 ± 2%, 
whereas in non-optimal patients, the improvement was 6 ± 3%, p<0.01, 
and in VO2 max the increase was 2.4 ± 0.3 ml/kg/min, as compared to 1.5 
± 0.4 ml/kg/min, p<0.01.  There was 1 patient with an optimal LV lead 
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position and 3 patients with a non-optimal LV lead who were categorised 
as inadequate responders based on clinical information with no subjective 
clinical benefit and based on echocardiographic information with a 
decrease in LV end-systolic volume of <15%.  This suggests that optimal LV 
lead position does identify a population of patients who might do better 
than non-optimal lead position, but that the population of patients with 
non-optimal lead position do still get some benefit from CRT. 
1.6  Optimisation of pacing 
1.6.1  Why the interest in AV optimisation? 
In the era of single chamber pacemakers, a constellation of symptoms 
and signs was described in 1969 by Mistui that later was named pacemaker 
syndrome9.  Although not well defined, it can present with symptoms as 
severe as syncope, pre-syncope, oedema, dyspnoea, and chest pain, or 
more moderately and subtly as lethargy, palpitation, or an awareness of 
venous pulsations.  These have been ascribed to the effects of atrio-
ventricular dyssynchrony, most commonly when there is ventricular atrial 
conduction and thus atrial contraction against a closed mitral valve during 
ventricular systole, thus transmitting a greater pressure into the neck vessels, 
and reducing ventricular filling and cardiac output.  These symptoms can 
also occur where there is competition between an intrinsic sinus rate and 
the paced ventricular rate, or indeed to a degree in patients with first degree 
heart block without a pacemaker, also known as a pseudo-pacemaker 
syndrome.  These symptoms can be alleviated by dual chamber pacing 
which allows the maintenance of atrio-ventricular synchrony.  However, 
the nominal settings of the device may not be optimal for an individual 
patient.  This may be because patients often have abnormal atria - dilated 
due to hypertension or valve disease, or indeed have degenerative changes 
in atrial conduction tissue.  If atrial conduction is slowed then despite a 
  57 
nominally appropriate atrio-ventricular delay, atrial contraction may in fact 
be occurring late and resulting in pacemaker syndrome. 
In the 1980’s it was possible to program different atrio-ventricular delays 
and this was demonstrated to have an impact on cardiac output114.  
Echocardiography has been used to optimise AV delays in right ventricular 
pacing.  Ritter et al conceived a simple method for calculating the 
appropriate AV delay in right ventricular pacing115.  
However, because dual chamber pacing has virtually eliminated the 
problem of symptomatic pacemaker syndrome116, individual optimisation of 
the AV delay is infrequently performed in these patients. 
Figure 1.5  Example of the Ritter method for AV optimisation.117.  This method 
programs two extreme AV intervals: a long AV interval with A wave attenuation 
(AVlong) and a short AV interval with A wave truncation (AVshort). For each 
AV interval, the time between the QRS complex onset to the completion of the 
A-wave is measured. The optimal AV interval is then calculated as below.
 
In patients with heart failure, there was interest in the use of dual 
chamber pacemaker therapy as a treatment modality.  Small initial studies 
did show some benefit and a mechanistic study by Nishimura et al 
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demonstrated in an acute human study that pacing with an optimum AV 
interval could improve cardiac output by up to 50%.  This benefit was 
greatest in those patients in whom the PR interval was so prolonged that 
atrial contraction occurred during ventricular systole such that it could not 
not contribute to ventricular filling.  They also concluded that the optimal 
AV delay varied significantly between patients so that individual 
optimisation was necessary to realise the benefits of pacing118.  A similar, 
but less profound benefit was demonstrated by Kinderman et al119. 
Subsequent work demonstrated that the long-term effects of right 
ventricular pacing was deleterious in heart failure, and therefore this has 
been superseded by biventricular pacing (see other chapter). 
 
1.6.2  Methods to optimise AV and VV delays. 
As described above, there are a number of methods that can be used to 
measure the change induced by altering the atrioventricular, and more 
recently for biventricular devices, the inter-ventricular delay.  The majority 
of studies have used echocardiography because it is non-invasive, easily 
accessible to clinical departments and can directly measure left ventricular 
filling using pulsed wave Doppler placed at the tips of the mitral valve 
leaflets.  The iterative method uses this method as described in figure 1.6. 
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Figure 1.6.  Iterative method.  Initially a long AV delay is programmed and the 
mitral inflow interrogated.  The AV delay is shortened in 20ms increments until 
truncation of the A wave occurs.  It is then lengthened in 10ms increments until 
the A wave is no longer truncated117.
 
Echocardiography can also be used to measure stroke distance and thus 
estimate cardiac output.  Although echocardiography is attractive, there is 
significant variability measured from beat to beat, partly due to true 
variation and partly due to variability in the placement of the sample 
volumes due to respiratory motion of the heart for example.  Other methods 
which have been used are invasive measurements of left ventricular 
pressures utilising high-fidelity pressure transducers placed in the left 
ventricle.  This allows the calculation of the rate of change in ventricular 
pressure, a surrogate for cardiac work.  However, the practical use of this is 
limited by the invasive nature of the technique. 
More recently, other non-invasive techniques have been described.  
These include beat to beat measurement of blood pressure using finger 
plethysmography, cardiac impedance to measure blood flow (a number of 
different techniques are available on the market).  There has also been 
interest in intracardiac measurements which have the potential to be used 
in devices to provide optimisation at any time, including PEA and 
intracardiac impedance measurements.  There has also been interest in 
optimisation using the surface ECG as well as intracardiac ECG’s. 
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Comparison of these techniques is hampered by the fact that there is no 
gold standard.  For example, one study defined the best setting as that 
which gave the greatest cardiac output by measurement of aortic stroke 
distance.  Unsurprisingly when using this definition they found that 
measurement of aortic stroke distance was the best technique and 
performed better than determination of the best setting by mitral inflow 
Doppler sampling120!  Furthermore, perfect concordance would not be 
expected in techniques with a degree of inherent variability, and where the 
change to be measured is small.   
1.6.3  The role of AV optimisation in biventricular pacemakers 
Kass et al performed acute invasive haemodynamic measurements in 18 
patients121.  They found that biventricular pacing and left ventricular pacing 
improved LV dp/dt compared to RV pacing or intrinsic rhythm.  They 
assessed different AV delays, and found that for most patients, the optimum 
value was around 120ms, with little change noted at different AV delays.  If 
the AV delay was less than 90ms, however, this compromised LV filling and 
consequently LV dp/dt.  Auricchio et al. also measured invasive 
haemodynamics in 25 patients during biventricular and univentricular 
pacing at different AV intervals and found that the best AV delay varied 
between individuals122.    Gold et al performed invasive measurements in 
28 patients at different AV delays123.  Again, they found that there was again 
a spread of optimal AV delays and that the optimum delay was significantly 
longer for a paced AV delay than a sensed AV delay (i.e. delay after an 
atrial pacing stimulus rather than atrial sensed event).  They also compared 
different methods of assessing the optimum AV delay against LV dp/dt as 
the reference standard.  2 echocardiographic optimisation methods were 
used - the Ritter method and the measurement of aortic VTI using 
continuous wave Doppler, as well as an algorithm using measurements 
derived from intracardiac electrograms from the pacing leads.  They found 
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the mean difference in optimum AV delay from that determined by the 
reference standard was least using the intracardiac electrograms, followed 
by the Aortic VTI and then the Ritter method.  Jansen et al also compared 
echo-guided optimisation methods against LV dp/dt in 30 patients124.  The 
found that mitral inflow VTI most frequently gave concordant results, 
followed by left ventricular outflow tract (LVOT) VTI, then diastolic filling 
time and finally the Ritter method. 
Stockburger et al. demonstrated that AV optimisation led to an 
improvement in echo-Doppler parameters including the myocardial 
performance index and left ventricular filling time fraction, over and above 
that offered by standard settings125. 
In a longer term study, Sawhney et al. randomised 40 patients 
undergoing CRT to an empiric AV setting of 120 ms or AV delay 
optimisation using echo Doppler to measure aortic velocity time-integral126.  
They assessed 8 different AV delays and found a significant difference in 
individual optimal settings between patients, although the best setting for 
the majority was between 100 and 140 ms. This translated into a clinical 
improvement, with significantly more patients that improving by one or 
more NYHA class (75% in the optimised group vs. 40% in the empiric 
group, P < 0.03) and a significantly larger improvement in quality of life 
score (23 ± 13 vs. 13 ± 11 points respectively, P < 0.03).  However, these 
changes were not translated into an improved 6-min hall walk distance 
(6MHW). 
Kedia et al published their experience with echo-guided AV 
optimisation127.  In a retrospective cohort of 215 patients, most of whom 
were optimised using Ritter’s method, they found that 40% of patients had 
an AV delay of >140ms - suggesting that a significant proportion of patients 
have an optimal AV delay significantly longer than nominal settings. 
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Hardt et al described the effects of echo-guided optimisation using 
LVOT VTI in 33 patients who were optimised on average 31 weeks after 
CRT implant128.  Approximately 6 weeks after optimisation the patients 
underwent follow up echocardiography, NT pro-BNP measurements and 
6MHW.  They found that optimisation led to a small improvement in LVEF, 
a fall in NT pro-BNP and an increase in 6MHW.  However, the lack of a 
control group makes it difficult to know what changes would be expected 
without optimisation. 
Zhang et al. performed serial echo-Doppler guided AV delay 
optimisation on 31 consecutive patients receiving CRT for standard 
indications immediately after device implantation, at 3 months, and then at 
long-term follow up (at least 6 months after CRT) 129.  Not only did they 
found that the spread of optimal delays was wide, but also a significant 
number of patients (58%) required at least one change in their AV delay at 
3 month or long-term follow up, suggesting that there may be a role for 
serial optimisations. 
However, in Zhang’s study, the agreement between the optimum AV 
delay as measured by echo-Doppler and by impedance cardiography was 
poor.  This is an issue that bedevils CRT optimisation, namely what is the 
best technique to do this.  Invasive studies might be the gold standard, but 
are not feasible for routine, multiple use.  Echocardiography has some 
variability and is highly user dependent.  Impedance cardiography, finger 
plethysmography are all also potentially useful and more reproducible 
techniques, but they require specialised equipment that may not be 
available in every centre.  
Melzer et al examined whether dyssynchrony was the mechanism that 
underlies the the benefit of AV optimisation130.  In 11 patients, they 
optimised the AV delay using Ismer’s method which utilises an oesophageal 
electrode to record left atrial electrograms, as well as concurrent echo-
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Doppler sampling of mitral inflow.  They measured dyssynchrony using 
tissue Doppler at the optimised delay and 50ms more or less than that 
optimum.  They did not find any significant change in dyssynchrony at the 
different AV delays, implying that it is purely alterations in ventricular filling 
that underlie the haemodynamic benefits of AV optimisation. 
Chawla et al published further on what appears to be the same cohort as 
the previous paper by Sawhney120,126.  They compared the Ritter’s method 
of optimisation versus the aortic VTI method. Interestingly, the correlation 
between the two methods was poor. 
Whinnett et al have demonstrated that non-invasive blood pressure 
monitoring can be used to optimise the AV delay both at rest and on 
exercise131.  Delnoy et al have demonstrated that an algorithm utilising 
peak endocardial acceleration signals from a specially designed lead can be 
used for optimisation as it correlates closely with invasive dp/dt across a 
series of AV delays{Delnoy:2008gq}. 
Waggoner optimised 30 patients using continuous wave Doppler 
echocardiography for aortic VTI and stratified the response by the degree of 
diastolic dysfunction at baseline132.  They found that optimisation had a 
significantly greater effect in patients with pseudo-normalised / restrictive 
filling at baseline. 
Jones optimised 30 patient by echo-Doppler of mitral inflow, and 
compared this to the ECG133.  They suggested that an AVD programmed to 
30-40ms after the end of the p wave on the surface ECG would 
approximate the optimum delay found by echocardiography. 
Valeur performed an observation study on 100 patients using a reference 
standard of the summed displacement of the 6 basal left ventricular 
segments measured using tissue Doppler echocardiography (DLV).  They 
found that DLV correlated well with LVOT VTI, a lesser correlation with 
E/e’ ratio and that it did not correlate with diastolic filling time. 
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One of the other issues in optimisation is that after making changes to 
the timing, there is an initial cardiac response which will affect 
haemodynamics, but compensatory peripheral vasculature changes can 
result in alterations in left ventricular filling and thus the steady state 
haemodynamics may not adequately reflect the magnitude of changes seen.  
This issue has not been considered by the echocardiographic community, 
but work by Whinnett and others elegantly demonstrates the changes in 
blood pressure seen on a beat to beat basis as measured by finger 
plethysmography134. 
1.6.4  The clinical basis for AV optimisation.  
Of the landmark studies demonstrating the effectiveness of CRT, the 
approach to optimisation differed widely.  The MUSTIC investigators did 
not perform AV optimisation29, whereas the MIRACLE31 and larger CARE-
HF34 studies performed echo-Doppler guided optimisation based on 
diastolic filling.  The COMPANION study also used optimisation based on 
intracardiac electrograms33.  Only one study thus far has been a randomised 
controlled trial of different AV delay strategies.  The SMART delay study 
randomised 980 patients into a strategy of a fixed AV delay of 120ms, a 
single pre-discharge echo-Doppler guided optimisation, or optimisation pre 
discharge and at 3 months using an algorithm based on intracardiac 
electrograms135.  The primary endpoint was LV end systolic volume 
measured by 2D echocardiography.  They found no difference in the 
primary endpoint between the three groups.  Neither were there any 
differences in the secondary endpoints which included functional measures 
such as change in 6MHW, change in quality of life scores or change in 
New York Heart Association class. 
The FREEDOM trial136 has yet to publish its findings, but preliminary 
results have been presented at Heart Rhythm 2010.  This study is 
comparing QuickOpt optimisation with standard clinical care which may 
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or may not include AV or VV optimisation.  They apparently have found no 
difference between the two groups. 
1.6.5  The role of VV optimisation 
Sogaard and others demonstrated that in some patients sequential 
biventricular (BiV) pacing has an additional benefit over simultaneous, and 
that the best settings varied significantly between individuals.  They 
assessed 20 patients soon after device implantation using echocardiography 
and found that VV optimisation resulted in an average absolute 
improvement in left ventricular ejection fraction of 3.9%137.  A number of 
studies have confirmed this acute benefit of sequential biventricular pacing 
using various techniques including invasive measurements of left 
ventricular dp/dt138,139, radionuclide ventriculography140, and 
echocardiography141. 
These small scale studies were followed by data coming from larger 
scale trials.  The InSync III investigators compared the effect of sequential 
biventricular pacing in 359 patients to that of patients enrolled in the 
MIRACLE study.  VV optimisation was performed by measuring stroke 
distance after implant and before hospital discharge, at 3 and at 6 months.  
The optimal setting was different to simultaneous biventricular pacing in 
approximately 80% of patients at each time point.  They found no 
difference in the NYHA functional class or quality of life between the 
optimised InSync III patients and the MIRACLE CRT patients, though the 
increase 6 minute hall walk distance was greater in the optimised group142.  
Boriani randomised 121 patients to echo-Doppler guided VV optimisation 
or simultaneous pacing but did not find any difference in 6 minute hall 
walk distance, NYHA functional class or quality of life143.  Forty-eight of 
these patients were followed up with echocardiography at 6 months, but 
there was no difference in echocardiographic remodelling between the 2 
groups144. 
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Vidal et al studied 31 patients and performed optimisation guided by 
tissue Doppler assessment of 2 opposing left ventricular walls.  They 
assessed 3 VV delays and found a poor correlation between optimal settings 
determined by surface ECG QRS duration and echo.  However, the 
correlation was better when measuring inter-ventricular delay on the 
surface ECG.  A further study by the same group looked at compared tissue 
Doppler with LVOT VTI and found that they agreed in 81% of patients145.  
Bertini et al however, studied 106 patients who had AV and then VV opt 
by echo146.  They found that an optimisation strategy based on minimising 
the paced QRS duration on the surface ECG showed a good concordance 
with echo determined optimal VV settings. 
Fischer et al looked at 47 patients referred to their optimisation clinic147.  
The optimised AV delay by mitral inflow, and VV delay by aortic VTI.  They 
found no clinical characteristics that could predict optimal VV settings. 
Sciariaffia used impedance cardiography and compared it to invasive 
dp/dt to determine optimum VV delays in 24 patients148.  They found a poor 
concordance in the optimum settings by the two methods. 
Marsan et al optimised 69 patients using echocardiography.  They found 
that the effects of VV optimisation were greater in patients with ischaemic 
cardiomyopathy than in patients with dilated cardiomyopathy.  
Furthermore, there was a significant interaction with the extent of 
myocardial scar, with patient with more scar requiring earlier LV 
stimulation149. 
Duvall et all reported on 74 consecutive patients referred for 
optimisation.  These patients had had their device implanted a mean of 9.9 
months prior to optimisation.  They measured aortic VTI and 3D LVEF at 5 
different VV delays.  They found that these methods frequently did not 
agree on the optimum setting, and in the majority of patients (83% by aortic 
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VTI, 71% by 3D LVEF) the optimum setting was simultaneous 
stimulation150. 
Herweg et al also performed late optimisation (mean 600 days post 
implant) in a consecutive series of 40 patients.  They found that echo-
guided optimisation using aortic VTI resulted in a QRS morphology on the 
surface ECG that was more suggestive of true biventricular pacing with a 
positive R wave in V1151. 
Khan et al performed optimisation by echocardiography.  They found 
that AV and VV optimisation provided an incremental improvement over 
AV optimisation alone, as assessed by non-invasive measurements of 
cardiac output.  They also defined the site of the left ventricular lead in 
relation to the most delayed left ventricular myocardial segment defined by 
echo radial speckle tracking.  They found that the benefit of VV 
optimisation existing in patients where the lead ventricular lead was sited 
adjacent to the most delayed segment rather than being directly over the 
segment or remote from it.  This suggests that VV optimisation can be used 
to overcome a mildly sub-optimal LV lead location152. 
Finally Tamborero randomised 156 consecutive patients to echo-
Doppler guided AV optimisation and tissue Doppler VV optimisation 
against echo-Doppler guided AV optimisation and ECG guided VV 
optimisation.  They found no difference in clinical endpoints between the 
two groups but a larger decrease in LVESV in the group whose VV delay 
was optimised by the ECG153. 
1.6.6  AV & VV optimisation 
Valzania et al reported on their cohort of 37 patients who underwent 
serial echo-guided AV and VV optimisations.  The Av delay was optimised 
based on diastolic filling and the VV interval by aortic VTI.  They found that 
there were significant changes to the optimum settings over the course of 1 
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year follow up154.  She also found that there were significant differences 
between optimal settings at rest and on exercise155.   
Baker et al found that there was a good concordance correlation 
coefficient between QuickOpt and aortic VTI measurements in 58 
patients61.  However, Van Gelder et al compared QuickOpt at implant with 
invasive LV dp/dt measurements and found that there was a poor 
concordance in the optimum setting between the techniques156.  Porciani 
examined the effect of QuickOpt settings on cardiac function in 20 patients 
using 3D echocardiography.  Using Qlab, they found that optimisation led 
to an acute fall in dyssynchrony and an improvement in SV and LVEF113. 
Zuber et al compared acoustic-cardiography against echo-guided 
optimisation in 43 patients.  The iterative method was used for AV 
optimisation and LVOT VTI for VV optimisation.  They found a good 
correlation between echo and acoustic cardiography for AV optimisation, 
but that the correlation was statistically significant, but less good for VV 
optimisation.  They performed multiple measurements at different settings 
to evaluate the reproducibility of both techniques, and found that the signal 
to noise ratio of VTI was worse than that of acoustic cardiography157. 
Khan validated non-invasive cardiac output monitoring against 
echocardiography for CRT optimisation158. 
Turcott and others also compared cardiac impedance with 
echocardiography for optimisation in 20 patients.  They looked at aortic 
VTI, mitral VTI, A wave truncation and septal-posterior wall motion delay.  
Measurements were made and averaged over 1 respiratory cycle.  They 
found that impedance cardiography was the most reproducible and was 
able to give a statistically significant estimate of the optimum setting.  The 
confidence interval was narrow.  However,  the echo measurements did not 
perform so well with only the Aortic VTI being able to give an estimate of 
the optimum AV interval and the confidence interval was wider than in 
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impedance cardiography.  Some of the variability that they encountered 
may be explained by motion of the heart throughout the respiratory cycle 
which would inevitably result in motion of the sample volume. 
Taha et al used a comprehensive echo-Doppler assessment to optimise 
AV and VV delays in 50 consecutive CRT patients referred for optimisation 
by the clinical cardiologist.  The average time from CRT implant was 13.8 
months and optimisation resulted in an acute improvement in echo systolic 
and diastolic characteristics as well as a longer term improvement in NYHA 
class and MLHFQ.  However, 10 out of these patients had no net 
improvement post optimisation159. 
Reinsch et al used inert gas rebreathing technique to measure cardiac 
output and performed AV and VV optimisation based on this.  They found 
that this technique worked, but didn’t compare it to other methods.  Having 
said that the interesting thing about this paper is that they measured the 
effect of reprogramming the device 10 minutes after reprogramming to 
allow for equilibration160.  This is the antithesis of Whinett’s strategy. 
Bogaard et al measured dp/dt during pacing at different LV epicardial 
sites in 16 patients.  They found that optimisation could partially 
compensate for a sub-optimal lead position161. 
Dizon et al used LIDCO to optimise 15 patients.  They did a subgroup 
analysis which suggested that patients with an acute improvement in SV 
with optimisation did better at 6 week follow up in terms of LVEF, LVEDD 
and 6MHW distance.  The subgroup analysis is probably meaningless 
though. 
Bocchiardo et al compared dp/dt with intracardiac impedance 
measurements for optimisation of LV lead position, AV and VV delays.  
They found that variations in the LV lead location resulted in a mean 
optimal benefit of 18.1% in dp/dt.  AV opt increased the benefit to 22.1%, 
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and VV delay opt also resulted in a benefit.  Impedance was correlated well 
with the optimal values by dp/dt. 
Pabari et al suggest that there needs to be an assessment of signal to 
noise ratio in the evaluation of techniques for CRT optimisation.  This 
appears sensible, and she has given an elegant mathematical description to 
support her hypothesis.  Unfortunately, there is no data on the signal to 
noise ratio for different techniques, nor indeed the recognition that for a 
given technique there is likely to be variation in this ratio between 
laboratories. 
More recently Ginks et al demonstrate that intracardiac impedance can 
be used to estimate optimum AV and VV delays using invasive dp/dt as 
their reference standard162. 
1.7  Summary 
Dyssynchronous activation of the heart associated with left bundle 
branch block or ventricular pacing has been known about for nearly 100 
years.  The advent of echocardiography and improvements in pacing have 
resulted in the development of sensitive techniques to detect dyssynchrony 
and to ameliorate it using biventricular pacing.  However, questions remain 
that this thesis will attempt to answer.  Does pacing the right ventricle at a 
site other than the apex result in less dyssynchronous left ventricular 
contraction?  Can 3D echo be used to assess optimal atrio-ventricular 
delays with pacing?  Does everyone with a biventricular pacemaker require 
individual optimisation, or is the benefit limited to an identifiable sub-group 
of patients.  Finally, can speckle tracking be applied to 3-D echo datasets to 
improve dyssynchrony assessment? 
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Chapter 2 AdviseCRT 
2.1  Abstract 
 The timing of atrioventricular (AV) delays may be adjusted in 
pacemakers.  The optimisation of this delay has been demonstrated to alter 
cardiac output.  We performed a clinical feasibility study to investigate the 
utility of cardiac impedance measurements to select the optimal AV delay.  
Measurements of impedance at different vectors were performed during 
implantation of a biventricular pacemaker through a specially designed 
pacemaker platform.  This was referenced against invasive haemodynamic 
measurements at time of implant and echocardiographic measurements 
performed at a later time.  There was poor correlation between impedance, 
invasive haemodynamics and echocardiographic measurements in selecting 
the optimal AV delay. 
2.2  Introduction 
The programming of artificial pacemakers requires the specification of 
the interval between atrial and ventricular pacing stimuli.  Whilst this is true 
of dual-chamber pacemakers, it has come into focus more recently with the 
development of biventricular pacemakers.  A number of different studies 
have demonstrated benefits in acute haemodynamics, surrogates of cardiac 
output and also echocardiographic parameters (see section 1.6.3).  A 
number of methods can be used to select the best interval in a given 
patient, but these methods are time consuming and only assess the patient 
at one moment in time. 
The ability for a pacemaker to self-optimise is an attractive concept as it 
might allow automatic and frequent optimisation of the pacemaker timing.  
One potential method is the measurement of electrical impedance.  This 
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method is currently used within pacemakers as a means to monitor the 
water content of the lungs as a surrogate for heart failure control (Optivol) 
163.  However, beat to beat changes in impedance may be a surrogate of 
cardiac function164. 
We therefore performed a clinical feasibility study to determine whether 
different methods of measuring cardiac function might ultimately be used to 
optimise pacemaker timing.  As a necessary precursor, we compared 
invasive measurements of left ventricular pressure, measurements of cardiac 
impedance and 2-dimensional and 3-dimensional echocardiographic 
assessments.  Therefore the null hypothesis was that there was no 
concordance of these methods for selecting the optimum AV delay. 
2.3  Methods 
2.3.1  Study Objectives 
The objective of this study was to determine whether the measurement 
of cardiac impedance through implanted pacemaker leads could be 
performed and might ultimately be used to optimise the atrioventricular 
delay.  As a necessary precursor we performed measurements of 
impedance, invasive haemodynamics and echocardiography and correlated 
these. 
2.3.2  Study design 
The study was a prospective, non-randomised clinical feasibility study, 
sponsored by Medtronic Inc.  Patients were recruited at Kings College 
Hospital, London and the University of Pittsburgh Medical Center, 
Pennsylvania, USA.  Both centres collected impedance data measured 
through the implanted pacemaker leads and performed Doppler and 2-
dimensional echocardiography after pacemaker implant.  The 
atrioventricular delay was varied and impedance measurements through the 
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pacemaker leads were compared to simultaneous pressure and volume 
measurements, as well as to subsequent 2-dimensional and 3-dimensional 
echocardiographic measurements with the same programmed intervals.  An 
additional sub-study was performed only at Kings College Hospital that 
gathered invasive left ventricular pressure and volume measurements and 
3-dimensional echocardiographic data after pacemaker implant.  This sub-
study was designed by the author and colleagues, the data acquired and 
analysed by the author as part of this thesis.  Offline echocardiographic 
measurements were performed by the author on all patients from both 
centres.  The analysis of cardiac impedance data was performed by Dr 
Todd Zielinski of Medtronic Inc.  Only data pertaining to the patients in this 
sub-study are presented here. 
The study was approved by the hospital ethics committee. 
2.3.3  Patient eligibility criteria 
Inclusion criteria were: 
1.  Patients scheduled for a new biventricular pacemaker / defibrillator 
(CRT-D) implant or CRT-D generator replacement 
2.  Patients greater than 18 years old. 
3.  Patients able and willing to give informed consent. 
Exclusion criteria were: 
1.  Patients with persistent or permanent atrial fibrillation 
2.  Patients who were pacemaker dependent. 
3.  Patients with an integrated bipolar defibrillation lead (as 2 RV pacing 
electrodes distinct from the defibrillation coil electrode were necessary for 
the impedance measurements). 
4.  Patients with hypertrophic cardiomyopathy. 
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5.  Patients enrolled in a concurrent study that might confound this 
study. 
6.  Patients who were pregnant. 
7.  Patients unable or unwilling to participate in study procedures. 
8.  Patients with acute cardiac ischaemia 
Withdrawal criteria: 
1.  If the patient wished to terminate study participation. 
2.  The Investigator, at his or her own discretion, could withdraw a 
patient from the study at any time if the patient’s well being could be 
jeopardised by continuation of the study. 
2.3.4  Implant set-up 
Immediately before CRT-D implant or replacement, a respiratory belt 
transducer (Biopac Systems Inc, CA, USA) was placed around the patient’s 
thorax and the transducer amplifier module was connected. The respiratory 
belt transducer measured the change in thoracic circumference that 
occurred as the subject breathes, without any electrical connection to the 
patient. The respiratory belt was contained outside the sterile field and 
therefore did not require sterilisation prior to use.  The patient was then 
cleaned and draped for implant.  The leads used for the clinical implant 
were placed transvenously in the right atrial appendage (CapsureFix Novus 
5076, Medtronic Inc), right ventricular apex (Sprint Quattro Secure, 
Medtronic, UK) and over the left ventricle using the coronary sinus to 
access a posterolateral or true lateral branch vein.  These were 
commercially available leads from Medtronic, Inc and the choice of left 
ventricular lead was at the discretion of the implanting physician.  The 
pacemaker pocket was created subcutaneously below the left clavicle and a 
Medtronic model # 5719 Active Can Emulator was temporarily placed 
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inside the pocket; this pocket was subsequently used for the patient’s 
device implant.  The study protocol was performed after implantation of the 
clinical leads, but before connection to the clinical device.  The Active Can 
Emulator (ACE) mimics the electrical and dimensional characteristics of the 
final patient implanted device in order to collect impedance vector data 
from the RV lead electrodes to the ACE electrode.  The transvenous leads 
and Active Can Emulator were connected via a Medtronic Header Kit 
model 5460 to the investigational Continuous Impedance Module Model 
19051 (cZm) via two patient cables (Medtronic Models 5420 & 5436).  The 
cZm allowed atrial and ventricular pacing together with simultaneous 
impedance measurements from specified poles of the leads.  The cZm and 
respiratory band were connected to a data acquisition module (MP150, 
Biopac Systems Inc, CA, USA) and respiratory transducer amplifier 
respectively (RSP100, Biopac Systems, Inc, CA, USA).    
Pressure volume measurements were performed using a 7 French 
conductance catheter (CA-71103-PL, CD Leycom, Netherlands).   Before 
implant the conductance catheter was calibrated against a 100mmHg 
standard and against atmospheric pressure.  A 7 French arterial sheath was 
placed in the femoral artery.  An Emerald 150cm J-tipped diagnostic 0.035” 
guide-wire (502-521, Cordis, UK) was used to place a Judkins Right 
Coronary JR4 catheter (Cordis, UK) into the left ventricle.  A 300cm ChoiCE 
extra support 0.014” wire (Boston Scientific, UK) had a J-shape formed at its 
tip and the Emerald J wire was exchanged for this.  The JR4 catheter was 
then exchanged for the conductance catheter.  The catheter was connected 
to a monitor for set-up and data acquisition (CFL-512, CD Leycom, 
Netherlands).  The conductance catheter measures impedance between 
10mm spaced electrodes on the catheter shaft.  This is proportional to left 
ventricular volume, and was calibrated using 3-dimensional 
echocardiographic measurement of left ventricular volume acquired just 
before the start of the procedure.  The measurement of impedance requires 
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injection of an electrical current.  Simultaneous measurements by the 
conductance catheter and the pacemaker leads were therefore physically 
impossible as the two devices simultaneously injected currents that 
interfered with one another.  The pacing interventions and impedance 
measurements from the pacemaker leads were performed as described 
below, with simultaneous pressure measurements from the conductance 
catheter whilst the catheter electrodes were deactivated.  To acquire 
pressure-volume loops, the pacing intervention had to be repeated with the 
conductance catheter active.  Pressure-volume data were analysed using 
software (ConductNT v3.18, CD Leycom, Netherlands). 
After the first 3 patients, the acquisition of pressure-volume data was 
deemed to add excessive time to the procedure.  This increased the risk of 
infection to the patient and therefore the collection of this data was 
abandoned and replaced with pressure only measurements that could be 
performed simultaneously to the impedance measurements. 
Pressure only measurements were performed using a high fidelity 
pressure transducer (Pressure wire Certus, St Jude Medical, UK).  This was 
placed via a right radial 6Fr sheath.  Again an Emerald J-wire and JR4 
catheter were placed in the left ventricle and the J-wire exchanged for the 
pressure-wire.  The JR4 catheter was then removed.  The pressure-wire was 
then connected via the RadiAnalyzer Xpress measurement system to the 
data acquisition module. 
In both scenarios 5,000 international units of heparin were administered 
intravenously to prevent thrombus formation on the wire.   The pressure 
signals were routed via the catheter laboratory monitoring equipment 
(Axiom Sensis, Siemens Healthcare, UK) to the applicable analog input 
channel on the data acquisition module.  After the procedure, haemostasis 
was achieved by use of an Angioseal (St Jude Medical, UK) if femoral 
arterial access, or a TR band (Terumo, UK) if radial arterial access was used. 
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The calibrated BioPac unit sampled the analog electrical output of the 
cZM, respiratory band and the pressure transducer at 2000Hz.  BIOPAC 
Acknowledge Data Acquisition Software was used to collect and store these 
real time signals using a laptop computer.  Real- time impedance waveform 
data was collected in four electrode configurations using conventional 
pacing leads for a minimum duration of two respiratory cycles.  
After measurements, the external pacemaker generator was 
disconnected, a Medtronic Protecta CRT-D device attached and the implant 
procedure completed in the standard method of the operator. 
2.3.5  Implant measurements 
The cZm was programmed to pace the atrium 10 beats per minute faster 
than the intrinsic sinus rate to ensure reliable capture.  The delay between 
atrial pacing and the subsequent ventricular sensed event on the right 
ventricular lead was measured through the pacemaker generator.  In order 
to achieve a completely paced beat (as opposed to one arising from fusion 
of pacemaker stimuli and intrinsic conduction) 10 ms was subtracted from 
this delay and this value was defined as 100% of the paced AV interval.  
Atrial and ventricular pacing was performed in DDD mode, sequentially at 
atrioventricular delays calculated to be 100%, 80%, 60%, 40% and 20% of 
the AV interval rounded to the nearest 10ms.  The second protocol added 
baseline (unpaced) and 30ms atrioventricular delay measurements (30ms 
delay was chosen as this was the smallest programmable value).  
Simultaneous impedance and pressure measurements were performed for 
approximately 20-30 seconds for each impedance configuration tested, to 
allow for 2 normal breath cycles of the patient.  Impedance measurements 
were performed with 4 different electrode configurations.  Each 
configuration was determined by a pair of electrodes to inject current, and 
a sensing pair of electrodes.  The configurations are defined in table 2.1.  
Offline pressure-volume loop analysis was performed using ConductNT 
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3.18 (CD Leycom, Netherlands).  Offline impedance and simultaneous 
pressure analysis was performed using AcqKnowledge 3.9 (Biopac Systems, 
CA, USA).  Three consecutive stable cardiac cycles were chosen for 
analysis and results averaged. 
Table 2.1 – Table of impedance vectors 
Configuration Injection electrodes Sensing electrodes 
1 - left ventricle RV ring & LV ring RV tip & LV tip 
2 - right ventricle RV tip & RV coil RV ring & RV coil 
3 - right atrium to 
right ventricle 
RA tip & RV tip RA ring & RV ring 
4 - RV to can RV tip & can RV ring & can 
 
The cZm was based on a pacing platform that allowed pacing from a 
single ventricular electrode during impedance measurements.  Initially this 
was engineered to pace the right ventricle.  This is not consistent with the 
clinical use of CRT-D devices which are predicated on pacing both 
ventricles simultaneously.  The cZm was re-engineered during the study, 
but was unable to allow biventricular pacing simultaneously with 
impedance measurements.  As left ventricular pacing may improve left 
ventricular function similarly to biventricular pacing and maybe 
programmed in a clinical device, the cZm was re-engineered to deliver left 
ventricular pacing rather than right ventricular pacing. 
2.3.6  Post Procedure echocardiogram 
Within 3 days of the procedure, the patient underwent 
echocardiographic assessment of cardiac performance to replicate the peri-
implant impedance protocol.  The pacemaker was programmed to DDD, 
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pacing the same chamber and at the same lower rate as used during 
impedance measurements.  The AV interval was varied to include 80%, 
60%, 40% and 20% of the intrinsic AV conduction; identical to those used 
during impedance measurements at device implant.  Measurements were 
performed at least 20 seconds after adjustment of AV interval. 
Echocardiographic assessment included pulsed wave Doppler of mitral 
inflow, left ventricular outflow, 2-dimensional echocardiography with 
apical windows optimised for the left ventricle along the three standard cut-
planes, as well as 3-dimensional acquisitions of the left ventricle.  This was 
performed using a Philips ie33 system with S5 and x3 transducers (Philips, 
UK). 
Doppler measurements were performed at a fast sweep speed of 100mm 
per second and optimised scale to maximise measurement accuracy.  Mitral 
inflow was interrogated using pulsed wave Doppler.  The E to A time was 
measured at least 3 times.  Mitral regurgitation was interrogated using 
continuous wave Doppler to measure LV dp/dt, at least 3 times.  Left 
ventricular outflow tract blood flow was assessed using pulsed wave 
Doppler.  The velocity time integral (LVOT VTI)  and the ejection time was 
measured on 3 beats.  The aortic flow was assessed using continuous wave 
Doppler.  Again the velocity time integral (Ao VTI) was measured 3 times. 
Apical 4 chamber and 2 chamber and 3 chamber views were recorded, 
with depth and sector width optimised for the left ventricle. At least 3 
consecutive beats were recorded.   
3-dimensional acquisitions with depth and sector width optimised for 
the left ventricle were performed.  These acquisitions were gated over 4 or 
7 consecutive cardiac cycles depending on the frequency of ventricular 
ectopy and patient tolerance during breath-holding in the phase of 
respiration that afforded the best image quality. 
The myocardial performance index was calculated as – 
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[time that mitral valve is closed – ejection time] / ejection time 
The time that the mitral valve is closed is measured as the time between 
the end of the A wave to the beginning of the E wave on mitral Doppler.  
The ejection time is measured on continuous wave Doppler through the 
aortic valve. 
Offline image analysis was performed using Xcelera 4.0, Philips and LV 
analysis 2.7, TomTec GmBh Germany.    Results were analysed using Excel 
2008 for Mac, Microsoft, WA, USA, Prism 5.0 for Mac OS X, GraphPad CA, 
USA and SPSS 19.0, IBM, USA. 
2.4  Results 
2.4.1  Patients 
In total 13 patients were recruited into the study, however 1 patient, 
K008, subsequently was withdrawn as the implant procedure was 
prolonged and it was felt that study measurements would add excessive 
time to the procedure and increase the risk of wound infection. 
The first patient underwent the procedure and measurements as 
planned, however, echocardiography was mistakenly performed during 
biventricular pacing as it was not appreciated that the cZm could only pace 
from a single ventricular lead.  Therefore impedance data is not available 
for comparison.  Three-dimensional echocardiography was not performed 
at the shortest AV delay at the patients request. 
The subsequent 6 patients, K002 to K007 were all performed during 
right ventricular pacing. 
After re-engineering the cZm, the protocol was changed such that the 
subsequent 5 patients, K009 to K013 were all assessed during left 
ventricular pacing. 
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Of the 6 patients who underwent measurements during right ventricular 
pacing, 2 of these had 3D echocardiograms that were not analysable.  One 
patient, K005, had such frequent ventricular ectopy that a gated 3D left 
ventricular acquisition was impossible.  Doppler and 2-dimensional 
assessments were acquired with difficulty and all measurements were 
performed on the second cycle after a ventricular ectopic beat.  Patient 
K007 had echocardiographic windows that were too poor to allow 3D 
analysis. 
Example pressure volume loops are shown in figure 2.1.  Whilst 
excellent loops were obtained in some patients, this was time consuming 
and abandoned as it was thought to add excess time and risk to the patient. 
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Figure 2.1  Pressure volume loops.  An example patient during intrinsic rhythm 
(upper panel), LV pacing with an AV delay of 160ms (middle panel) and 120ms 
(lower panel).  The segmental loops are on the left, the global LV loop is 
bottom right and summary data in the upper right.  In intrinsic rhythm the 
cardiac function is poor with a stroke volume of 31ml and the shape of the loop 
indicates inefficient cardiac work.  During LV pacing there is a “square” shaped 
loop indicating efficient cardiac function and much better haemodynamics with a 
stroke volume of 63 ml.  There is little difference between the AV delays 
shown.   
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2.4.2  Optimum AV delay 
The mean optimum AV delay as ascertained by dp/dt was 78% of the 
maximum paced AV delay with a standard deviation of 18%, and a range 
of 60-100%.  No patients had an optimum AV delay below 60% of the 
maximum AV delay.  Figure 2.2 shows a frequency histogram of the 
optimum AV delays. 
Figure 2.2 – Frequency histogram of optimum AV delays. 
 
 
2.4.3  3-Dimensional echocardiography to determine optimum 
AV delay 
The utility of 3-dimensional echocardiographic methods was determined 
by comparing the optimum selected AV delay with that determined by 
dp/dt.  The mean optimum AV delay was shorter with all 3D methods than 
dp/dt by 16%, though this was not significant (p>0.05).  The ranges were 
wide suggesting a poor concordance in selecting the same AV delay as that 
by dp/dt.  Figure 2.3 is a box plot showing the median, interquartile ranges 
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Figure 2.3 – Box plot showing median, interquartile ranges and 95% confidence 
interval of the % difference between 3D methods and dp/dt. 
 
2.4.4  Doppler echocardiography and Cardiac Impedance to 
determine optimum AV delay 
The utility of Doppler and Cardiac Impedance methods was determined 
by comparing the optimum selected AV delay with that determined by 
dp/dt.  The mean optimum AV delay was shorter with myocardial 
performance index (32%) and LVOT VTI (7%), though these were not 
significant (p>0.05).   
Similarly, all cardiac impedance vectors selected a shorter AV delay 
than dp/dt, though these were not significant (p>0.05).   Wide ranges for all 
measures suggest a poor concordance in selecting the same AV delay as 
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ranges and 95% confidence interval of the % difference between the 
methods.. 
Figure 2.4 – Box plot of difference in AV delay for each method against dp/dt.  
The box indicates the median difference and the interquartile range.  The 
whiskers indicate the 95% confidence interval. 
 
 
2.5  Conclusions 
 Simultaneous pressure-volume and cardiac impedance measurements 
were physically impossible using these techniques as intracardiac volume 
assessments are performed using impedance which physically interfered 
with simultaneous impedance measurements from the pacing system. 
The agreement between pressure and cardiac impedance measurements 
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and left ventricular pacing.  Furthermore the agreement between these 
methods and echocardiographic methods was also poor.  Finally, even 
within the modality of echocardiography there were discrepancies in the 
best atrioventricular delay between different measurements. 
This study was not designed to investigate the reasons behind these 
findings.  However, a number of different issues can be considered which 
may have been responsible for the variability seen. 
Firstly, the role of homeostatic mechanisms governing cardiac filling.  
Alterations to the atrioventricular delay results in acute effects on cardiac 
filling and output, but compensatory mechanisms exist influencing venous 
return which may have an impact on cardiac output.  Although Gold and 
colleagues have demonstrated the utility of dp/dt in selecting 
atrioventricular delays123, other studies by Whinnett and others have 
demonstrated that it is easier to select the best atrioventricular delay when 
making many measurements immediately following changes to the 
atrioventricular interval165. 
Secondly, alteration of the atrioventricular delay was not performed in a 
randomized manner.  The sequential assessment of AV delays from long to 
short may have influenced homeostatic mechanisms and is a limitation of 
the study. 
Thirdly, the inherent variability of the methods used to assess the 
atrioventricular delay.  If the variability is significant in comparison to the 
differences being measured, then chance alone might account for the 
different atrioventricular delays measured.  Reproducibility of 
measurements such as LV dp/dt assessed by echocardiography was not 
performed in this study. 
Thirdly, comparison of echocardiographic data acquired 3 days after 
implantation may be affected by loading conditions.  Patients were fasted 
before their procedure and therefore likely to be intravascularly deplete.  
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Patients were not fasted for their echocardiogram so their intravascular 
volume is likely to have been different.  Patients also found 
echocardiography after CRT implant uncomfortable.  The wound remained 
tender and they were being asked to lie in a left decubitus position.  This 
may have had an impact on the patients sympathetic tone.  Furthermore, 
the alteration from sinus rhythm to biventricular pacing for three days prior 
to echocardiography may have had an impact on cardiac remodelling 
already and response to single ventricular chamber pacing. 
Finally, the fact that the intervention was performed during atrial and 
ventricular pacing may be significant.  Pacing 10 beats above the intrinsic 
sinus rate at time of implant means that many patients were paced at 70-90 
beats per minute.  The pattern of ventricular filling is strongly influenced by 
the heart rate and length of the diastolic interval.  E and A wave fusion 
occurs at higher heart rates.  The heart rates used here were physiological 
but significantly above that of the the target resting heart rate and indeed 
actual resting heart rate in this cohort of patients. 
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Chapter 3 RV mid-septal or apical pacing 
3.1 Abstract 
Right ventricular apical pacing leads to left ventricular dyssynchrony.  
Using real-time 3-dimensional echocardiography, we compared the effects 
of right ventricular apical and mid septal pacing on left ventricular 
contraction. 
An observational cohort study was performed on 64 patients scheduled 
for pacemaker or defibrillator implant.  Real time 3 dimensional 
echocardiography was performed both in intrinsic rhythm and during 
pacing. 
Overall, pacing led to an increase in dyssynchrony and a fall in ejection 
fraction in both groups, though this was greater with apical pacing than 
with mid-septal pacing.  Stratification by left ventricular function indicated 
that in patients with normal left ventricular function there was no difference 
between apical and septal pacing, whereas in patients with left ventricular 
dysfunction there was a greater increase in dyssynchrony and fall in 
ejection fraction with apical versus mid-septal pacing. 
Real time 3-dimensional echocardiography enables the accurate 
assessment of left ventricular volumes, ejection fraction and dyssynchrony 
in patients with pacemakers.  Apical pacing causes acutely increased 
dyssynchrony and lower ejection fraction than mid-septal pacing, though 
this appears to be limited to those patients with left ventricular dysfunction. 
3.2  Introduction 
Endocardial right ventricular apical pacing is the conventional method 
of delivering pacemaker therapy.  However, this pacing has been 
demonstrated to lead to impaired cardiac output, left ventricular systolic 
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dysfunction71, long term structural changes as seen by histology166 as well 
as increased morbidity and mortality25.  Furthermore biventricular pacing 
has recently been demonstrated to improve outcomes compared to right 
ventricular apical pacing in patients with pre-existing left ventricular 
systolic dysfunction167. 
These detrimental effects may be the results of dyssynchronous left 
ventricular contraction.  Alternative locations for right ventricular pacing 
have been sought which may obviate some of these detrimental effects.  
The other locations that have been investigated include the right ventricular 
outflow tract, mid-septum, upper septum and septal-his bundle.  The 
existing literature is conflicting with several studies indicating that right 
ventricular outflow tract pacing leads to better haemodynamics and less 
dyssynchrony72, though other studies have been unable to reproduce 
this80and there is no conclusive evidence of clinical benefit from alternate 
site pacing168,169.  Three-dimensional and tissue Doppler echocardiographic 
dyssynchrony assessment has indicated that both right ventricular apical 
and outflow tract pacing leads to greater dyssynchrony than sinus 
rhythm83,170. 
There are fewer data regarding mid-septal pacing and dyssynchrony.  
Cano and others investigated the effects of mid septal and apical pacing in 
patients with normal left ventricular ejection fraction after the first week of 
implant and at 6 and 12 months using tissue Doppler echocardiography171.  
Septal pacing was associated with less dyssynchrony than apical pacing at 
12 months, though there were no changes in left ventricular ejection 
fraction or in clinical parameters.   However Ng and others found increased 
circumferential strain dyssynchrony with chronic septal pacing compared to 
apical pacing and lower ejection fraction172.  Part of this discrepancy may 
be accounted for by the heterogeneity in the site of pacing. 
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We hypothesised that pacing the right ventricular mid-septum would 
produce less dyssynchrony and greater left ventricular ejection fraction than 
right ventricular apical pacing as determined using real-time 3-dimensional 
echocardiography. 
3.3 Methods 
An observational parallel cohort study was performed on patients 
undergoing pacemaker or defibrillator implant.  Patients were eligible for 
inclusion if they were over 18 and were scheduled for pacemaker or 
defibrillator implant.  Patients who were pacing dependent were excluded. 
Pacemakers or defibrillators were implanted using standard techniques, 
at the usual site preferred by the operator.  Lead position was adjudicated 
by researchers after implant by reviewing fluoroscopy in both right anterior 
oblique 30 degree and left anterior oblique 40 degree projections, as well 
as post procedure radiographs. 
The apical location was recorded if the tip of the lead was pointing 
downwards in an area within 2 cm distance from the apical border of the 
heart.  The mid septal location was recorded if the lead tip was 
approximately at the level of the superior aspect of the tricuspid valve in the 
right anterior oblique projection, and was pointing toward the left ventricle 
in the left anterior oblique position, with an angle between 0 and 80 
degrees173 to ensure that the septum was being paced rather than the free 
wall or the anterior aspect of the right ventricle.  Patients with leads outside 
these areas were excluded from the analysis. 
In patients in sinus rhythm, the sensed atrio-ventricular delay was 
reduced to the minimum value to determine the ECG morphology of a 
completely paced beat, and then the sensed AV delay was increased to the 
either the longest value that allowed complete pacing without getting 
fusion, or to the nominal sensed atrio-ventricular delay was programmed 
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where this resulted in a completely paced beat.  In patients in atrial 
fibrillation, the lower rate of the device was set to 10 beats per minute 
higher than the mean intrinsic rate.  It is assumed that this eliminated fusion 
beats.   
Echocardiography was performed during intrinsic rhythm and during 
pacing in all patients within 72 hours of implant.  Philips iE 33 machines 
were used together with S5 and X3 transducers (Philips Healthcare, 
Guildford, Surrey, UK).  Three-dimensional datasets were acquired over 4 
or 7 consecutive beats during breath holding, depending on the ability of 
the patient to hold their breath.  Image acquisition was optimised by 
adjusting depth to include the mitral valve annulus and exclude the left 
atrium, as well as adjusting the density of the scanning sector.  Datasets 
were inspected for quality and stitching artefacts before storing.  Datasets 
were stored on line and imported into Research Arena platform (TomTec 
Imaging Systems GmbH, Munich, Germany).  Analysis was performed using 
LV analysis 2.7 (TomTec Imaging Systems GmbH, Munich, Germany).  This 
software did not display the electrocardiogram enabling analysis to be 
performed by an operator blinded as to whether a dataset was acquired 
during intrinsic or paced rhythm.  Furthermore, patients were excluded if 
the image quality of the dataset was inadequate.  This was defined as 
datasets with stitch artefact, echocardiographic dropout of 4 or more 
segments, or poor endocardial definition of 4 or more segments. 
Electrocardiography was performed during intrinsic and paced rhythm. 
Results were recorded into a database created using Bento 2.0 
(Filemaker, Inc, Santa Clara, California, USA) and analysed using Excel 
2008 (Microsoft, Seattle, Oregon, USA), SPSS 19 (IBM Armonk, New York, 
USA) and GraphPad Prism 5.0 (GraphPad, La Jolla, California, USA) 
Based on pilot data, a power calculation was performed to estimate the 
sample size required.  Based on a mean baseline ejection fraction of 50% 
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and a standard deviation of 9%, it was estimated that 28 patients were 
required in a group to detect an absolute change in ejection fraction of 5% 
due to pacing with a power of 81% using a paired two-tailed Student’s t-
test.  Adjustment for the variability of echocardiographic results was not 
made. 
The results were analysed using two-tailed paired Student’s t-tests within 
groups and unpaired Student’s t-tests between groups. 
3.4 Results 
A total of 64 patients were recruited into the study.  Six of these (9.4%) 
were excluded due to image quality.  A further 3 patients were excluded 
because the right ventricular lead was sited at the right ventricular outflow 
tract.  Baseline characteristics are listed in Table 3.1.  The mean age of 
patients was 73 years in both groups p=0.49, with a similar prevalence 
between the groups of hypertension (36% and 37% in apex and mid-septal 
groups respectively p=0.92), duration of the electrocardiographic QRS 
complex (109 vs. 117ms, p=0.41),ischaemic heart disease (43% vs. 33% 
p=0.47), valvular disease (7% vs. 26% p=0.06) and high degree AV block 
(21% vs. 37% p=0.2) as an indication for their device.  Patients with apical 
leads were more likely to have diabetes mellitus (21% vs. 4% p=0.05) and  
implantation of defibrillators (39% vs 7% p=0.01) compared to patients in 
the mid-septal group.  
There were no significant differences in procedure time or screening 
time between the groups.  Mean implant duration and standard deviation 
was 92 +/- 29 minutes in the apical group compared to 90 +/- 28 minutes 
in the mid-septal group p=0.79.  Similarly, fluoroscopy times were 7.3 +/- 
4.0 minutes in the apical group and 9.5 +/- 7.1 minutes in the mid-septal 
group p=0.17. 
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Table 3.1 - Baseline characteristics.  Asterix indicates p value <0.05 
 Apex Mid-septum 
Total 28 27 
ICD    39%(11)*  7% (2) 
EF>50 54%(15) 48% (13) 
High degree AV 
block 
21% (6)  37% (10) 
Mean age (years +/- 
SD) 
72.8 +/- 12.3 73 +/- 13.2 
IHD 43% (12) 33% (9) 
DM  21% (6)* 4% (1) 
Hypertension 36%(10) 37% (10) 
Valve disease 7%(2) 26% (7) 
Intrinsic QRS (msec 
+/- SD)  
109 +/- 39 117 +/- 29 
 
In intrinsic rhythm, there was no significant difference between the 
groups for end-diastolic and end-systolic volumes, ejection fraction or 
systolic dyssynchrony index, as listed in Table 3.2.  With pacing, the end-
diastolic volume fell by 6ml in the apical group and 7ml in the mid-septal 
group.  However, there was a differential response in the end-systolic 
volumes between the groups with the end-systolic volume increasing with 
pacing in the apical group by 4ml, but falling by 2ml in the mid-septal 
group.  The cumulative effect of these changes in volumes resulted in a 
significant fall in ejection fraction in both groups (paired t-test for change in 
EF p<0.001 for both groups) as shown in figure 3.5, the magnitude of which 
was significantly greater in the apex group (absolute fall of 9% in apex 
group vs. 5% in mid-septal group, p=0.02) as demonstrated in figure 3.2.  
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Apical pacing also led to a significantly higher SDI than mid-septal pacing 
(6.7 vs. 5.2, p=0.03) as seen in figure 3.6.  There was no difference in QRS 
duration with apical pacing than mid-septal pacing (156ms vs. 140ms, 
p=0.61). 
Table 3.2 - Effects of pacing at different locations.  Asterix indicates P value 
<0.05 












99 +/- 31 93 +/- 28 99 +/- 49 92 +/- 43 
ESV (ml 
+/-SD) 
52 +/- 22 56 +/- 22 53 +/- 40 51 +/- 34 
EF (% +/- 
SD) 
48 +/- 11 39 +/- 13* 50 +/- 10 45 +/- 10* 
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Figure 3.1  3D analysis of a patient in baseline rhythm.  The upper left panel 
shows a short axis cut of the endocardial cast.  The upper right panel shows the 
4ch cut, and the lowere left panel shows a bullseye plot.  The volume graphs for 
each of 16 segments is shown in the lower right panel.  There is very little 
dispersion in the time to minimum volume across the segments, indicating 
synchronous contraction.  Ejection fraction was 47%, SDI 1.9%
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Figure 3.2.  The same patient with apical RV pacing.  There is now more 
dispersion seen in the time to minimum volume in the lower right panel.  The 
EF was 39%, SDI 5.8%.
 
Figure 3.3  Another patient at baseline.  EF is 63%, SDI 2.7%
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Figure 3.4.  The same patient as 3.3 during mid-septal RV pacing.  The dispersion 
of time to minimum volume remains small  Ef 61%, SDI 2%.
. 
Both groups were further stratified by baseline ejection fraction, as 
summarised in tables 3.3 and 3.4.  In 28 patients with a baseline ejection 
fraction of >50%, both apical and mid-septal pacing led to a similar fall in 
end-diastolic volumes (8ml vs. 9ml), but no significant change in end-
systolic volumes (3ml vs. 1ml).  There was a significant fall in ejection 
fraction seen in both groups due to pacing (9% in apical group, p<0.001, 
6% in mid-septal group p=0.008), with no significant difference between 
the groups (p=0.19).  Apical pacing was associated with a mean SDI of 4.6, 
whereas mid-septal pacing led to an SDI of 4.3, p=0.29. 
However, in 27 patients with a baseline ejection fraction <50%, pacing 
from either apex or mid-septum did not appear to alter end-diastolic 
volumes (0 vs -5ml respectively p=0.39), but apical pacing caused an 
increase in end-systolic volume, which was not seen with mid-septal 
pacing (6ml vs -1ml p<0.01).  Cumulatively this resulted in a significant fall 
in ejection fraction with apical pacing (9%, p=0.01 paired t-test), but not 
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mid-septal pacing (4%, p=0.29 paired t-test) but with no significant 
difference between the groups  in ejection fraction(9% with apical pacing 
vs. 4% with mid-septal pacing, p=0.06) or SDI(3.3% with apical pacing vs. 
0.1% with mid-septal pacing, p=0.07).  Relative changes were statistically 
significant, with apical pacing resulting in a 23% relative fall in ejection 
fraction vs 6% in mid-septal pacing (p=0.03) and the relative rise in SDI 
being 74% vs 15% (p = 0.03). 
 
Table 3.3 - Effects of pacing in patients with normal ejection fraction.  Asterisk 
indicates p<0.01 
















90 +/- 32 82 +/- 28 86 +/- 43 77 +/- 35 
ESV (ml 
+/-SD) 
40 +/- 17 43 +/- 17 37 +/- 19 36 +/- 17 
EF (% +/- 
SD) 
57 +/- 5 48 +/- 7* 57 +/- 3 52 +/- 6* 
SDI (% +/- 
SD) 
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Table 3.4 - effects of pacing in patients with low ejection fraction 


























64 +/- 19 72 +/- 17* 68 +/- 49 67 +/- 39 
EF (% +/- 
SD) 
39 +/- 8 30 +/- 10* 42 +/- 10 38 +/- 9 
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Figure 3.5 - Figure 1. Box and whisker plot showing LV ejection fraction during 
intrinsic rhythm and pacing in apex and mid-septal regions.  Paired t-test 
indicates a significant fall in ejection fraction in both groups, p<0.01 
 
 
Figure 3.6 - Box and Whisker plot showing change in LV ejection fraction due to 
pacing in apex and mid-septal regions. Box indicates 25th and 75th percentiles 
with whiskers indicating 5th and 95th percentiles. P value for difference = 0.02. 
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Figure 3.7 - Box and Whisker plot showing change in SDI due to pacing in apex 
and mid-septal regions. Box indicates 25th and 75th percentiles with whiskers 
indicating 5th and95th percentiles.  P value for difference between apex and 
mid-septum = 0.03. 
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Figure 3.8 - Box and Whisker plot showing absolute change in LV ejection 
fraction due to pacing in apex and mid-septal regions, stratified by baseline LV 
ejection fraction.  Box indicates 25th and 75th percentiles with whiskers 
indicating 5th and 95th percentiles.  P value for difference between apex and 




These data demonstrate that pacing causes an acute fall in left 
ventricular ejection fraction when measured using real-time 3-dimensional 
echocardiography.  This appears to be to be due to falls in the end-diastolic 
volume as well as changes in the end-systolic volume.  The magnitude of 
change is greater in patients who are paced from the right ventricular apex 
than the right ventricular aspect of the mid inter-ventricular septum.  
Furthermore, this acute difference appears more pronounced in patients 
with a low baseline ejection fraction of <50%.  These alterations in volume 
and ejection fraction are accompanied by a corresponding increase in the 
systolic dyssynchrony index, suggesting that increased dyssynchrony may 
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Another technical explanation that might account for part of the 
alterations in volumes observe is that pacing may alter the triggering of the 
echocardiographic acquisition.  Multi-beat acquisition requires the 
scanning matrix to be repositioned before the start of the next beat resulting 
in loss of part of diastole.  Normally, acquisition is performed by triggering 
the acquisition on the peak of the electrocardiographic R wave.  However, 
during pacing, triggering frequently occurs on the pacing spike, before the 
R wave.  This will bring forward the acquired part of the cardiac cycle, and 
therefore true end-diastole may be missed.  This might account for the 
smaller end-diastolic volumes seen with pacing in both groups, however, it 
is unlikely to have had a significantly different effect between the two 
groups and is therefore unlikely to be the sole reason for the observed 
changes in volumes and ejection fraction. 
This study is limited in that although dataset analysis was blinded, 
patients were not randomly assigned to either group.  The baseline 
characteristics indicate that there was a greater prevalence of diabetes and 
implantable defibrillators in the apical group, indicating that the groups are 
different.  The rationale behind lead site selection for defibrillator leads may 
be different to that for pacing leads.  Defibrillator leads are not expected to 
pace the heart frequently, and they are required not only to sense and pace 
the heart but also allow a good vector for defibrillation energy delivery to 
the ventricular myocardium.  Furthermore, there is little published data 
regarding the placement of defibrillator leads outside the apical site. 
However, the fact that this was an acute study means that long-term 
differences in the frequency of pacing is unlikely to have impacted on the 
results. 
The subgroup analysis suggests that patients with impaired left 
ventricular function are more sensitive to the effects of pacing, particularly 
from the apex.  This study cannot elucidate the mechanism for this, but it 
generates a hypothesis to be tested in future studies.  For clinical care, it is 
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important that the group of patients with mild to moderately impaired left 
ventricular function continue to be studied to determine the optimal 
pacemaker therapy for them.  The recent Block-HF trial indicates that 
biventricular pacing is superior to right ventricular apical pacing in patients 
with impaired LV function167.  Septal pacing is less complex than 
biventricular pacing and requires a similar implant time as conventional 
apical pacing.  It therefore would be an interesting comparator against 
biventricular pacing in patients with impaired LV function. 
Follow-up of our cohort might demonstrate longer term differences in LV 
function, but would be confounded by differences in the percentage of 
ventricular pacing between patients as well as the effects of 
revascularisation or changes in valvular function. 
This study has demonstrated that it is feasible to assess left ventricular 
function before and after pacing using real-time 3 dimensional 
echocardiography.  This technique has a great deal to offer in the long-term 
follow up of patients with pacemakers as it is accurate, non-invasive, does 
not require radiation, is becoming widely available and is safe.  Whilst 
pacemakers have now been developed which allow MRI scans to be 
performed, they are not yet universally available from all manufacturers and 
have a cost implication so this modality will not be routinely available in 
pacemaker patients for some years to come.  In the interim, 3-dimensional 
echocardiography offers the best technique to follow and study pacemaker 
patients. 
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Chapter 4  Do we need to optimise? 
4.1  Abstract 
Cardiac resynchronisation therapy has entered clinical practice with the 
routine use of echocardiography guided optimisation of pacemaker stimuli. 
An observational cohort study was performed of 145 patients scheduled 
for cardiac resynchronisation therapy.  Real time 3 dimensional 
echocardiography was performed at baseline, early after cardiac 
resynchronisation therapy and before and after Doppler echocardiographic 
optimisation. 
There was improvement in LV systolic function after CRT.  The SDI at 
baseline and the change in SDI with CRT were statistically significant 
predictors of echocardiographic response.  There was no good correlation 
between any parameters and the response to optimisation, though the 
frequency of echocardiographic response to optimisation was higher in 
those patients who remained dyssynchronous after CRT. 
4.2  Introduction 
Cardiac resynchronisation therapy has been demonstrated to be an 
effective treatment in selected patients with heart failure.  Nevertheless, a 
clinical response is not seen in approximately 30% of patients.  Strategies to 
improve response rates are therefore attractive.  The initial trials of CRT 
implantation such as CARE-HF required optimisation of atrioventricular 
delays, and this has therefore entered clinical practice34.  Numerous small 
clinical trials have demonstrated that optimisation of atrio-ventricular and, 
to a lesser degree, inter-ventricular delays can acutely improve cardiac 
output120,126,137,139,174.  However, a larger scale trial SMART-AV which 
randomised patients to an empirical AV delay, echocardiographically 
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optimised AV delay or intracardiac electrogram optimised AV delay did not 
show significant benefits of optimised delays over an empirically 
programmed delay135.  This has cast doubt on the clinical utility of 
atrioventricular optimisation. 
There are a number of reasons why CRT optimisation may not be 
clinically useful.  Firstly, the increment in cardiac output achieved by 
optimisation may be clinically negligible.  Secondly, methods of 
optimisation may not be reliable enough to be reproducible.  Finally, the 
optimised setting may change over time and in different patient situations 
such as exercise or volume status. 
We hypothesised that CRT optimisation was of greater benefit in the 
sub-group of patients who remained dyssynchronous after CRT 
implantation, rather than in those patients in whom CRT had restored 
synchronous left ventricular contraction.  We sought to identify this group 
by performing an observational cohort study where all patients underwent 
echocardiographic CRT optimisation.  Stratification of echocardiographic 
response to optimisation was performed on the basis of real-time 3D 
echocardiographic dyssynchrony assessment early after CRT implantation. 
4.3  Methods 
4.3.1  Patients 
Patients scheduled for CRT implant between 2008 and 2012 were 
recruited into this study.  All patients were eligible and gave permission for 
their clinical records and the data acquired during clinical 
echocardiography to be analysed for research purposes.  Demographic 
information, prior medical history, medication use and the results of 
functional assessment and quality of life questionnaires were gathered from 
the patient records.  Approval for this study was obtained from the 
institutional review committee. 
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4.3.2  Study Procedures 
Baseline testing of patients included clinical assessment to determine the 
New York Heart Association Class of heart failure severity.   A 12 lead ECG 
was performed together the completion of the Minnesota Living with Heart 
failure questionnaire and measurement of the six minute hall walk distance.  
The definition of left bundle branch block was as described by the World 
Health Organisation 
Patients underwent 3-dimensional echocardiography as previously 
described54, as part of their work-up for CRT.  CRT was implanted using 
conventional transvenous methods.  After implantation, 3-dimensional 
echocardiography was performed within 72 hours prior to hospital 
discharge.  All patients were offered CRT optimisation at a median of 3 
months after implantation.  This time period was chosen clinically to allow 
a degree of remodelling to have occurred prior to optimisation and 
therefore that the settings determined at implant were likely to be 
appropriate for a longer future period.  Subsequent optimisations were 
scheduled at the discretion of the clinicians, but were not included in this 
study.  Patients were assessed at every visit to the hospital for device follow 
up and long term follow up was determined at the latest contact before May 
2014. 
Optimisation was performed using a standard protocol as described 
below.  Before optimisation 3-dimensional left ventricular volumes were 
acquired.  Subsequently atrioventricular optimisation was performed using 
pulsed wave Doppler echocardiography.  The CRT device was interrogated 
to determine if the device was predominantly sensing atrial activity or 
pacing the atrium, and therefore determine if the sensed atrioventricular 
delay or the paced atrio-ventricular delay were to be optimised.  If the 
patient was in atrial fibrillation, the optimisation of the atrio-ventricular 
interval was impossible.  The longest atrioventricular interval that allowed 
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capture of the ventricle was determined on the basis of the surface ECG.  
This atrioventricular interval was programmed and measurements were 
performed.  The interval was subsequently decreased in 20 millisecond 
steps and measurements were performed at each of these intervals. 
Pulsed wave Doppler was used to interrogate mitral inflow just below 
the level of the mitral valve leaflet tips.  Because of the dilatation of the 
mitral annulus that is frequently seen in CRT patients, which results in the 
direction of peak flow being at an angle to the cardiac axis, care was taken 
to align the signal as parallel to the direction of flow as possible, as 
determined by colour flow imaging.  The mitral valve leaflet closure 
artefacts were avoided as these may occur prior to true valve closure if the 
anterior mitral valve leaflet crosses the sample volume prior to leaflet 
closure.  Similarly pulsed wave Doppler was performed in the left 
ventricular outflow tract, just below the aortic valve.  At least 3 waveforms 
were recorded, during the same phase of respiration that afforded the best 
image quality.  Ventricular or atrial ectopic beats and the 2 subsequent 
beats were excluded because of the effects of the ectopic beats on 
ventricular filling.  Changes to the atrioventricular interval were made, and 
subsequent cardiac cycles acquired before manual measurement of the 
waveforms was performed.  This minimised the time taken to acquire the 
waveforms and to minimise variation due to differences in location of the 
pulsed volume sample. 
Measurements were made to calculate the myocardial performance 
index (MPI).  This is a measure that is independent of heart rate and is a 
measure of cardiac efficiency.  The index is the ratio of the duration of the 
isovolumic time to the ejection time, with a lower number indicating more 
efficient cardiac contraction.  This measure takes into account alterations in 
the ejection phase that occur as the atrioventricular interval is manipulated.  
This is calculated by the measurement of the time interval between the end 
of the A wave and the beginning of the E wave (A-E time) using mitral 
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inflow pulsed wave Doppler.  This interval is the time period when the 
ventricle is not filling.  The time for ejection was also measured (Ej time) 
using left ventricular outflow tract pulsed wave Doppler.  The Ej time was 
subtracted from the A-E time to give the isovolumic time, and divided by 
the Ej time, giving the MPI.  The echocardiography machine was 
programmed with this formula to calculate the MPI.  The MPI was 
calculated for each interval using averages of 3 measured cardiac cycles.  
The lowest figure was taken to reflect the optimum atrioventricular interval 
and this was therefore programmed175. 
 
Figure 4.1  Four images demonstrating the calculation of the Myocardial 
performance index.  The A-E time is measured at least 3 times.  The Ejection 
time is also measured at least 3 times.  The echo machine has been 
programmed to automatically calculate the average MPI.  The panels show a 
measurement at 2 example sensed AV delays of 160ms and 120ms.  120ms is 
determined to be the optimum setting with an MPI of 0.67, as compared to 
160ms which has a higher MPI of 1.05
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Subsequently, inter-ventricular optimisation was performed.  The CRT 
device was programmed to an inter-ventricular delay of 0ms, and the delay 
was varied in 15ms increments up to 60ms.  If the CRT device was unable 
to program these intervals, the closest programmable interval to these 
settings was used.  The atrio-ventricular delay was kept at the value 
determined in the previous step, but was defined as the time between the 
atrial event and the first subsequent ventricular pacing stimulus.   CRT 
devices from different manufacturers calculate the atrio-ventricular delay 
differently - for example, Boston Scientific devices define the atrio-
ventricular delay with respect to the timing of the right ventricular pacing 
stimulus, not the first ventricular stimulus, so the programming of the device 
took this into account where applicable.  Blood flow through the left 
ventricular outflow tract was measured using pulsed wave Doppler.  Again, 
acquisition of at least 3 cardiac cycles during the same phase of respiration 
was performed, with serial acquisitions at different inter-ventricular delays 
being performed before the waveforms were traced to minimise the 
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potential for changes in the pulse volume location.  An observer identified 
several individual points on the waveform with the software joining these 
points with a straight line to trace the borders of the waveforms.  The area 
of the waveform is the integral of velocity over time and gives the stroke 
distance.  The best inter-ventricular delay was taken to be the delay with 
the maximum average stroke distance.  To mitigate against variability, 
subsequently further acquisitions were performed at an inter-ventricular 
delay of 0ms and at the best inter-ventricular delay in the previous step.  
The best inter-ventricular delay was accepted as the optimum inter-
ventricular delay if the stroke distance was again measured to be greater 
than that at an inter-ventricular delay of 0ms.  3-dimensional echo left 
ventricular volumes were acquired at the optimum inter-ventricular delay. 
Analysis of 3-dimensional volumes was performed off line using TomTec 
LV analysis software V2.7.  Furthermore, the observer subjectively graded 
the image quality of the volumes into categories of good, fair or poor.  
Datasets were deemed not analysable if 4 or more segments were not 
visualised throughout the cardiac cycle or if there was significant stitch 
artifact.  Twelve datasets were further analysed by another operator to 
assess inter-observer variability. 
Data was collected on aetiology of heart failure, New York Heart 
Association functional class, 6 minute hall walk distance and Minnesota 
Living with heart failure questionnaire. 
4.3.3  Outcome measures 
Left ventricular ejection fraction was assessed using 3D 
echocardiography prior to optimisation.  The change from baseline was 
used as a medium term response to CRT therapy.  Immediately after 
optimisation left ventricular function was assessed using 3D 
echocardiography.  This allowed the immediate change due to optimisation 
to be measured.  Long term symptomatic response was assessed using New 
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York Heart association functional class and the Minnesota living with heart 
failure questionnaire prior to CRT implantation, at optimisation and at long 
term follow up.  Six minute hall walk distance was also measured prior to 
implant and at optimisation.  Data was collected regarding death and 
hospitalisation.  
4.3.4  Statistical analysis 
Inter-observer variability was assessed by initially using the Shapiro 
Wilkins test to verify the normality of distribution of each variable.  Where 
the variable was not normally distributed a square root transformation was 
performed to restore normality.  The single measures intraclass correlation 
coefficient (ICC) was calculated.  A Bland-Altman analysis was also 
performed to assess the mean difference between observers and the limits 
of agreement. 
The response to cardiac resynchronisation therapy was assessed using a 
repeated measures analysis of variance with Maunchly’s Test of sphericity 
and correction with Greenhouse-Geisser estimates where appropriate.  
Individual determinants of response were investigated using a univariate 
analysis of variance. 
To investigate the utility of post CRT SDI measures to predict the 
outcome of CRT optimisation it was decided that the best 
echocardiographic outcome metric was the 3D assessment of left 
ventricular function.  Alternative metrics such as a change in device settings 
such as AV and VV delay was deemed inappropriate as it does not quantify 
the effect of altering the settings.  Furthermore Doppler echocardiographic 
indices were deemed inappropriate because these indices were used to 
determine optimum device settings. 
The production of a receiver operating characteristic curve for the 
outcome of CRT optimisation was considered, but this requires 
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dichotomising the outcome into response or non-response.  As the outcome 
measure has a degree of noise in the signal, dichotomising the outcome 
measure may be incorrect and also loses the magnitude of change elicited.   
Therefore the best method was deemed to be the use a cut-off 
determined from previous work.  Kapetanakis et al demonstrated the 
likelihood of response to CRT was low in patients who had an SDI value of 
less than 7.5 prior to CRT112.  This value was therefore investigated as a cut-
off for response to CRT optimisation.  The cohort was dichotomised on this 
basis and the mean change in ejection fraction after optimisation 
compared.  Levene’s test for equality of variances was used followed by a 
two tailed homoscedastic Students T-test 
The Shapiro-Wilk test was used to verify if residuals obtained on analysis 
of variance did approximate a normal distribution.  If the distribution was 
not normal, the variables were mathematically transformed to restore 
normality before analysis.  Categorical variables were compared using Chi 
squared or Fisher’s exact tests, as appropriate. Paired continuous variables 
were compared using paired Student’s t tests.  Where more than 2 repeated 
measures were available a repeated measures ANOVA was performed 
together with Maunchly’s test of sphericity and correction with 
Greenhouse-Geisser estimates as appropriate.  Survival curves were plotted 
using the Kaplan-Meier method and compared using a log-rank test. The 
mean duration of follow-up was computed using the reverse Kaplan-Meier 
method. Statistical analyses and figures were obtained using PASW version 
19.0 (IBM, Bois-Colombes, France) and GraphPad Prism (GraphPad 
Software, La Jolla, CA). 
4.4  Results 
Of 145 consecutive patients undergoing CRT, 3D echocardiography was 
attempted in 129 and successful in 96.  Twelve patients were excluded 
because of software incompatibility.  A total of 84 patients therefore entered 
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the study.  Full echocardiographic data was available in 74 because 7 died 
before optimization, 1 patient refused post procedure echocardiography 
and 2 patients did not attend optimization despite repeated invitations.   
4.4.1  Baseline Characteristics 
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4.4.2  Inter-observer variability. 
Twelve patients were randomly selected for repeat analysis of 3D 
echocardiographic datasets by another operator.  Single measures Intraclass 
correlation coefficients (ICC) for ejection fraction, end systolic volume and 
systolic dyssynchrony index were calculated.  The ICC for ejection fraction 
was 0.870 with a 95% confidence interval of 0.611 to 0.961.  The ICC for 
end systolic volume was 0.894 with a 95% confidence interval between 
0.684 to 0.968.  The Shapiro Wilkins test demonstrated that SDI was not 
normally distributed (p=0.033) and therefore a square root transformation of 
the values was performed to restore normality.  The single measures ICC for 
SDI (square root transformed) was 0.927.  A Bland Altman analysis was also 
performed to calculate the mean difference between operators.  For SDI the 
mean difference was -0.1.  
4.4.3  Response to CRT 
Ejection fraction was measured at baseline, within 72 hours of CRT and 
before and after optimisation at a median of 105 days post CRT.  There was 
an increase in ejection fraction seen at each time point.  This is illustrated 
in Graph 4.1.  The series of figures 4.2 to 4.5 demonstrate a single patient at 
baseline, early after CRT and before and after optimisation. The Ejection 
fraction was normally distributed and the serial change in ejection fraction 
was statistically significant with a p value of <0.001 (repeated measures 
ANOVA test with Greenhouse-Geisser correction).  
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Figure 4.2  3D assessment of a single patient at baseline.  The upper left panel 
shows a short axis view of the endocardial case, the upper right a long axis 
view.  The lower left panel is a bulls eye plot of all 16 segments.  The activation 
wavefront is seen over the endocardial casts.  Individual segmental motion is 
plotted in the lower right panel.  The ejection fraction was 16% and SDI 14.0%
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Figure 4.3  3D assessment of the same patient after CRT.  The panels are in the 
same order as Figure 4.2.  The graph indicates some improvement in 
dyssynchrony.  The EF was 26% and SDI 7.7%.
 
Figure 4.4  The same patient before optimisation.  In this figure the lower right 
panel gives the numerical results.
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Figure 4.5.  After optimisation (AV and VV).  The ejection fraction has increased 
from 30 to 32% with a small drop in SDI from 5.7 to 5.4.
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Graph 4.1   This graph shows a box plot of ejection fraction at baseline (EF 1), 
within 72 hours of CRT implant (EF 2), before optimisation (EF 3) and 
immediately after optimisation.  The horizontal line indicates the median 
ejection fraction at each time point, the boxes enclose the 25th to 75th 
percentiles of the range and the whiskers enclose approximately 95% of the 
range.  When assessed with a repeated measures ANOVA test, the serial 
change in ejection fraction over the 4 time points was statistically significant 
p<0.001 




4.4.4  Determinants of response 
The determinants of response were investigated using univariate analysis 
of variance. The relative change in ejection fraction between baseline and 
before optimization was used as the dependent variable; rhythm, QRS 
morphology, sex and aetiology as factors and EF1, SDI1, SDI1-SDI2, EF2, 
6MHW at baseline, Minnesota living with heart failure questionnaire at 
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SDI1 (p=0.018) and SDI 1-2 (p=0.001) were significant predictors of 
relative change in ejection fraction.  Graphical representation in figures 4.2 
to 4.4 indicate the spread and the R squared value reflects the degree of 
response variable variation due to SDI 1-2 (19.5%), SDI 1 (11%) and QRS 
duration (5%) in the linear model. 
Assessing the effect of factors, the estimated marginal means after 
correcting for covariates indicated that the relative change in ejection 
fraction was greater in patients in sinus rhythm than those with atrial 
fibrillation; with Left Bundle Branch block as compared to Right bundle 
branch block, women more than men, and patients with dilated 
cardiomyopathy or valvular disease compared with patients with ischaemic 
heart disease. 
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Graph 4.2  A plot of relative change in ejection fraction against change in SDI 
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Graph 4.3  Relative change in Ejection fraction plotted against Systolic 
Dyssynchrony Index at baseline.  A linear regression line is plotted.  The R2 
value of 0.113. 
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Graph 4.4  Relative change in Ejection Fraction plotted against QRS.  A linear 
regression line is shown.  The R2 value of 0.052. 
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Graph 4.5  Box-plot demonstrating the relative change in ejection fraction 
between baseline and before optimisation categorised by QRS morphology.  
Normal refers to a QRS of ≤120ms.  NSIVCD refers to a QRS of >120ms that 
did not meet WHO criteria for left or right bundle branch block. 
 
  126 
Graph 4.6  Graph showing mean and 95% confidence intervals for the relative 
change in ejection fraction between baseline and before optimisation as 
categorised by QRS morphology.  P value for comparison <0.05
 
4.4.5  Effect of optimisation 
Further exploratory analysis was performed on the ability to predict 
change in ejection fraction due to optimisation.  Graph 4.7 plots the 
absolute change in ejection fraction peri-optimisation against absolute 
change in SDI before and after CRT implantation.  A horizontal line at an 
increase in absolute ejection fraction of 2.5% has been superimposed.  We 
suggest this value empirically as a marker of the acute response to 
optimisation.  The graph suggests that there is no clear relationship between 
the two variables.  This is confirmed on univariate analysis.  
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Graph 4.7  Absolute change in ejection fraction peri-optimisation plotted against 
absolute change in SDI before and after CRT implantation.  Regression confirms 
no statistical correlation between change in ejection fraction and change in SDI 
(R square 0.01) 
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Graph 4.8 plots absolute change in ejection fraction due to optimisation against 
SDI2.  Regression confirms no statistical correlation between change in ejection 
fraction and SDI2 (R square 0.14) 
 
 
This again indicates no linear relationship between the two variables.  
However, the proportion of patients who have a benefit from optimization 
is greater in patients with a higher SDI after optimization. 
Previously, an SDI of 7.5% has been suggested to be a lower limit for 
response to CRT112.  We found 51 (69%) patients had an SDI of <7.5% and 
in this group of patients the mean benefit of optimisation was 0.97% 
increase in absolute ejection fraction.  In the 23 patients with an SDI of 
>7.5% the benefit from optimisation was significantly larger at 2.52% 
absolute increase in ejection fraction (p value = 0.044).   
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Graph 4.9  Change in Mean Ejection fraction due to optimisation stratified by 
SDI2.  Graph shows mean +/- 95% confidence intervals.  P value <0.05
  
4.4.6  Clinical outcome of CRT 
The mean NYHA class at baseline was 2.8, 2.3 at optimisation and 2.5 
at long term follow up.  The frequency of NYHA class is shown in Graph 
10.  The distribution of patients changed with a greater proportion of 
patients improving into NYHA class I to II.  Minnesota living with heart 
failure questionnaire (MLHFQ) at baseline was 37.3, at optimisation 33.7 
and 33.1 at follow up. 
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Graph 4.10  Plot of patients stratified according to NYHA functional class pre 
CRT implantation, at optimisation and at follow up.  The width of the boxes 
indicates the proportion of patients in each class.  
 
At baseline the mean 6MHW distance was 322.1m with a standard 
deviation of 119.8 and at optimisation this had increased to 378.9m with a 
standard deviation of 109.2, with the mean change being 56.8m.  A paired 
t-test had a 95% confidence interval in the change in 6MHW distance to be 
between 34.2m and 79.4m with a p value of less than 0.001.  Six minute 
hall walk distance was not recorded at long term follow up. 
The MHLFQ was used to assess symptoms of heart failure.  At baseline, 
the mean score was 42.2 with a standard deviation of 24.1.  At optimisation 
the mean score had fallen to 32.4 with a standard deviation of 25.  At long 
term follow up the mean score was 32.9 with a standard deviation of 19.8.  
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A paired t-test indicated that the difference between baseline and 
optimisation was statistically significant with a p value of 0.005. 
Thirteen patients died during follow up.  Eleven patients were 
hospitalised for any reason. 
4.5  Conclusions 
These data demonstrate that serial real-time 3 dimensional 
echocardiography can be successfully performed in the majority of patients 
undergoing CRT. 
They confirm prior studies that 3D assessment of mechanical 
dyssynchrony prior to CRT can predict medium term echocardiographic 
response54,112.  They also indicate that modulation of dyssynchrony by CRT 
is a statistically significant predictor of medium term echocardiographic 
response.  However, these variables account for 30% of the variation in 
response. 
It is not surprising that dyssynchrony does not account for more of the 
variation in response, as there are many factors that can modulate response 
to CRT, not least the presence of scar and the location of left ventricular 
pacing.  The treatment may be able to influence some of these but not 
others.   
We hypothesized that the assessment of dyssynchrony immediately after 
CRT may be useful in the prediction of outcome from CRT optimization.  
All patients were optimized using a standardized Doppler 
echocardiography protocol, and immediately after optimization, the effect 
was assessed using an independent criterion namely 3D echocardiography 
Overall, a minority of patients had an improvement in ejection fraction 
following optimisation.  These patients are heterogeneous, with some 
patients being super-responders who have little to gain from optimisation, 
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whereas other patients do not respond and cannot be made to respond by 
altering the timing of pacing stimuli.  The group in whom altering the 
timing of pacing stimuli does make a difference is small. 
Nevertheless, those patients who remained dyssynchronous post CRT 
had a greater benefit from optimisation than those who had a lower SDI.  
Sixty nine percent of the cohort had a low SDI following CRT, so 
concentrating optimisation efforts on the remaining 31% would 
significantly reduce the number of optimisations performed. 
Despite a careful protocol, some patients appeared to have a decrease in 
ejection fraction following CRT optimization and this may reflect the 
inherent variability of both optimization and the technique used to measure 
it.  The variability informed the decision to analyse these patients as a group 
rather than perform a receiver operating characteristic curve using a 
empirical cut-off for response that would be close to the noise due to 
variability. 
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Chapter 5  Three-dimensional echocardiographic 
Speckle tracking 
5.1  Abstract 
The ability to track specular patterns seen in echocardiographic imaging 
of myocardial tissue has been demonstrated in 2D echocardiography.  It is 
attractive to extend this method into 3 dimensions.  In this study we used 
novel software to analyse 3 dimensional datasets and explored the inter-
observer variability of the measurements obtained.  Further work to 
minimise this variability was performed.  Whilst agreement for volumes and 
ejection fraction was good, agreement was less good for measures of 
dyssynchrony, global longitudinal strain, twist and torsion.  Further work 
needs to be done to improve the reproducibility of these measurements 
before their clinical utility can be investigated. 
 
5.2  Introduction 
Speckle tracking has been developed in 2 dimensional 
echocardiography as a method to quantify directional strain and 
displacement.  It relies on tracking the grey-scale pattern produced by 
reflection and refraction of ultrasound by the myocardium throughout the 
cardiac cycle.  There are limitations to speckle tracking related to the fact 
that the pattern of speckles must be stable enough through the cardiac cycle 
so that tracking can occur.  This means that image quality must be good, 
but also that the pattern must be stable enough despite the fact that 
myocardial movement occurs in three dimensions and thus can go out of 
the 2 dimensional imaging plane.  There is therefore a great deal of interest 
in extending speckle tracking techniques into three dimensions. 
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Three dimensional speckle tracking echocardiography may also have 
advantages compared to border detection algorithms.  Border detection 
algorithms may incorrectly track in regions with significant trabeculation 
and especially with left ventricular papillary muscles.  Automation of the 
border detection process is frequently inaccurate and requires manual 
editing.  Speckle tracking based algorithms should be less affected by 
papillary muscle, can generate information on strain that cannot be 
obtained by border detection algorithms as well as giving directional 
information that may be particularly relevant to dyssynchrony assessment. 
We therefore evaluated the feasibility and reliability of novel 3 
dimensional speckle tracking software in the assessment of volumes, 
ejection fraction, dyssynchrony assessment and strain values within 
observers, between observers and between 2 institutions.  This basic 
validation work is necessary before exploring the research and clinical 
utility of these tools. 
5.3  Methods 
This work was a collaboration between Kings College Hospital, the 
University of Chicago and TomTec imaging systems who produced the 
software.   
Echocardiography was performed on both sites, using Philips ie33 
systems, with a either x3 and x5 probes.  Full volume datasets were 
acquired over 4 cardiac cycles during breath-holding as previously 
reported.  Where possible, the depth, width and elevation of the volume 
was minimised to focus on the left ventricle alone. 
Datasets were analysed from 10 healthy subjects, 10 patients who had 
left bundle branch block (LBBB), but no other cardiac or medical diagnoses 
(normal & LBBB), 10 patients with dilated cardiomyopathy (DCM) and left 
bundle branch block, and 10 patients who had dilated cardiomyopathy and 
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no evidence of bundle branch block or intra-ventricular conduction delay 
on the surface ECG.  These datasets had previously been acquired for 
another research study on conventional 3 dimensional echocardiographic 
analysis.  Subsequently further datasets were acquired both in Chicago and 
at Kings and added to this cohort in order to replace those deemed to have 
insufficient image quality.  
Off-line echocardiographic analysis was performed using TomTec 
Research Arena platform version and module LV analysis 3.0 for 
conventional border detection analysis, as well as TomTec Image Arena 
platform and modules 4D cartesian export, LV analysis 4.0.  A specially 
constructed MatLab tool was also used for the exclusion of segments and 
calculation of dyssynchrony and strain parameters.  The method for using 
module LV analysis 3.0 is covered earlier in this thesis.  4D cartesian export 
and the LV analysis version 4 have a different workflow.  The workflow in 
4D cartesian export is based on LV analysis 3.0.  After opening the dataset 
in the module, the dataset is oriented so that the central axis intersects the 
apex of the left ventricle and the middle of the mitral valve in the apical 4 
chamber, 2 chamber and 3 chamber views.  The end systolic and diastolic 
frames are then defined.  The border is manually traced at end-diastole.  
This provides the starting points for speckle tracking strain analysis, but this 
module can also produce conventional 3-dimensional parameters if the 
border is subsequently traced at end-systole too.  At the next stage, border 
tracking is checked frame-by-frame border and edited if necessary as in LV 
analysis 3.0.  This editing does not alter the output of the speckle tracking 
module, but does alter the conventional 3-dimensional parameter output.  
After this stage, the conventional parameters are output.  Data is then 
exported before analysis using TomTec tracking modules.  This module 
processes the data and exports movie files of long and short axis cuts 
throughout the cardiac cycle.  The baseline speckle pattern is indicated by 
a green dot and red dots indicate that location as it moves through the 
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cardiac cycle.  This allows a visual analysis of the quality of the tracking.  
Darker points indicate areas outside the ultrasound sector that are not 
tracked, but are interpolated from the surrounding segments.  The module 
also output numerical parameters, strain, velocity, integrated displacement 
which is the 3-dimensional distance from the end-diastolic point as well as 
left ventricular volumes for every time-point.  Strain and velocity 
parameters have 3 components, circumferential, longitudinal and radial.  
Integrated displacement also has a further angular component that is 
calculated. 
The module LV analysis 4.0 has a more automated workflow.  After 
importing a dataset, the orientation of the left ventricle is adjusted and the 
reference frame defined.  The software then produces a border which is 
displayed in the 4 chamber, 2 chamber and 4 chamber views as well as the 
short axis.  If, as is usually necessary, the border requires editing, it can be 
selected and dragged to the correct area.  When the operator is satisfied 
with this starting point, progressing to the next step generates a border that 
is tracked throughout the cardiac cycle.  This can be inspected 
simultaneously in 3 longitudinal and 3 short axis cut-planes and edited if 
necessary.  Editing the borders in this step results in recalculation of the 
speckle tracking.  This editing step was thought to perform relatively poorly 
and therefore operators were encouraged to go back and edit the initial 
border in preference to editing after tracking.  The final step delivered 
parameters in summary and graphical format as well as allowing export in a 
format compatible with Microsoft Excel.  This output could also be 
imported into a bespoke MatLab tool that allowed individual segments to 
be included or excluded from the overall analysis as well as calculating 
standard deviations for any of the displacement or strain parameters.  As 
this was a simpler workflow than the previous version, all datasets were 
reanalysed using this version.  Revision builds were provided by TomTec as 
they were finalized. 
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The dyssynchrony parameters produced by the software included the 
measure SDI-I which was analogous to SDI-16 from the contour detection 
method.  This measure was the standard deviation of time to peak strain of 
each of the 16 segments.  It also generated a novel measure SDI-II which 
incorporated apical rocking into the measurement.  There were measures of 
Global Longitudinal Strain, twist and torsion also.  
Figure 5.1  Aligned volume.  The volume has been opened in LV analysis 4.0.  
The volume has been rotated along the axes to that the axis goes through the 
apex and the mitral valve.  The aortic valve has been marked in the short axis 
view (SAX, upper left panel) to aid the software in recognizing the standard 2,3 
and 4 chamber long axis cuts (3Ch upper right, 2Ch lower left and 4Ch lower 
right respectively). 
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Figure 5.2.  The software generates an endocardial border at a single timepoint 
in the cardiac cycle.  This is visible next to the moving image and can be 
manipulated to ensure accurate placement of the border.  After this step the 
software tracks the border and generates the moving endocardial cast.  This can 
then be visulaised throughout the cardiac cycle to ensure a good fit.
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Figure 5.3  Output of LV analysis 4.0.  This figure shows the 3D cast in the 
upper right panel, bullseye plot upper left panel, numerical results lower left 
panel and graph of 3D strain against time in lower right panel.
 
 
5.3.1  Statistics 
Bland – Altman plots were used as the primary method for visual 
analysis of reproducibility57.  These plot the difference between observers 
against the mean value for an individual data point.  This highlights 
systematic bias, any trends in this bias across the range of mean values, as 
well as allows the calculation of the limits of agreement, defined as +/- 
1.96*standard deviation of the differences between observers.  The limits of 
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agreement are likely to be wide in a pilot study involving limited numbers 
of datasets, and therefore the intraclass correlation coefficients were 
calculated58.  Analysis was performed using Excel 2008 for Mac. 
5.4  Results 
Initially, 2 datasets were exchanged between the centres and analysis 
performed.  This revealed similar values for ejection fraction, a bias in 
volumes, a reasonable correlation for SDI-I and a less good correlation for 
SDI-II.  We then proceeded to blinded analysis of the rest of the cohort.  
The mean values for each group, as well as the mean differences are shown 
in Table 5.1.  In the normal group, 8 out of 14 patients had to be excluded 
for a number of reasons, including stitch artefact (2 patients), missing 
datasets (3 patients), volume acquisition optimised for RV rather than LV 
volume (1 patient), insufficient frame rate to open (3 patients).  The mean 
difference for end diastolic and end systolic volumes was 12.5 and 9.6 ml 
respectively, which gives a smaller mean difference of 2.8ml for stroke 
volume and 4.2% for ejection fraction.  The bias was for the Chicago group 
to generate smaller volumes in this cohort.  Proportionally there was a 
greater difference for SDI-I, with a mean value of 6.5%, but the mean 
difference between groups being 3% i.e. nearly half of the value being 
measured.  The mean SDI-II was 5.5%, with a mean difference of 1.3% 
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Of the DCM patients, 4 were excluded, 2 because of stitching artefacts 
and 2 because the author deemed the tracking to be too poor for the results 
to be meaningful.  The mean end diastolic and systolic volumes were much 
larger than the normal group at 227.8ml and 180.2 ml respectively.  The 
mean differences were proportionately lower than the normal patients at 
7.3ml and 7.8ml respectively.  The ejection fraction in these patients was 
also much lower than the normal patients at 22.2%, with a mean difference 
of 0.6%.  SDI-I and SDI-II values were higher than the normal patients at 
12.1% and 13.5% respectively, but the mean differences in SDI were high 
at 10.4% for SDI-I and 9.6% for SDI-II. 
Of the patients with left bundle branch block, there were clear 
differences between the two groups in the analysis of those deemed 
otherwise to be normal.  Only 4 patients were analysed at both sites, yet 
there were large differences in the volumes obtained.  The mean EDV was 
123.6ml, with a mean difference of 41.3ml, and the mean ESV was 71.2ml 
with a mean difference of 36.7ml.  However the stroke volumes were 
similar with a mean of 51.4ml and a mean difference of 4.5ml.  Ejection 
fraction differed between the groups with a mean of 43.2%, but a mean 
difference of 11.8%.  SDI-I and SDI-II values were better than others groups 
with a mean SDI-I and SDI-II of 8.4% and 8.0 %, with mean difference of 
1.7% and 0.7 % respectively.  Those patients with left bundle branch block 
and a dilated cardiomyopathy had much larger volumes with a mean EDV 
of 282 ml, and a mean difference of only 6ml, a mean ESV of 235.1ml and 
a mean difference of 5.8ml.  Consequently ejection fraction was also lower 
than other groups at 17.7%, but a mean difference of only 0.3%.  Again 
SDI-I and SDI-II had marked differences between the two sites, with mean 
values of 12.2% and 15.5%, but mean differences of 5.7% and 2.4% 
respectively. 
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Bland-Altman plots for individual patients are plotted (see Figures 5.4 to 
5.9) and these confirm the above impressions - that the author generated 
significantly larger volumes and lower ejection fraction in normal 
ventricles, though in abnormal ventricles the mean values for volume and 
ejection fraction were very good.  However, there was significant 
divergence in the values for dyssynchrony between the groups. 
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Figure 5.4  Bland Altman plot for End Diastolic Volume.  Solid line indicates bias 
and dashed lines indicate 95% confidence intervals.
 
Figure 5.5  Bland Altman plot for End Systolic Volume.  Solid line indicates bias 
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Figure 5.6  Bland Altman plot for Stroke Volume.  Solid line indicates bias (-1.4 
ml), dashed lines indicate 95% confidence intervals (+/- 19ml) 
 
Figure 5.7  Bland Altman plot for Ejection Fraction.  Solid line indicates bias and 
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Figure 5.8  Bland Altman plot for SDI-I.  Solid line indicates bias and dashed lines 
indicate 95% confidence intervals
  
Figure 5.9  Bland Altman plot for SDI-II
 
We investigated the reasons behind the variability in dyssynchrony 
measures.  Many of the datasets from the Chicago group included 2 
“loops”.  The terminology can be confusing as each full volume dataset is 
made up of 4 smaller volumes acquired over 4 consecutive heart beats, but 
the Philips ie33 machine has the ability to acquire for a longer period than 
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acquired which can be single or dual for 3D acquisitions.  It was realised 
that the TomTec software used at both sites was a different software 
revision, and that the Chicago group had the earlier iteration of the software 
which was unable to parse 2 loop acquisitions as separate loops and 
therefore the peaks were distributed across both loops resulting in large 
values for dyssynchrony.  This was confirmed by a comparative analysis in 
a single patient of single and dual loop acquisitions by the Chicago group 
who demonstrated that the dyssynchrony parameters were doubled in the 2 
loop acquisition, whilst the volumes remained identical.  We also realised 
that the groups had not been analysing the same volume as each patient 
had multiple volumes acquired, and furthermore the initialisation frame 
differed between the groups, with the Chicago group setting the initial 
border at end-systole, whilst the author had set the initial border at end-
diastole. 
We therefore proceeded to repeat the analysis after standardisation of 
the method.  The software version used was confirmed to be identical at 
both sites, the individual volume to be analysed for each patient was 
defined, and it was decided to use the end-systolic frame as the 
initialisation frame.  The end-systolic frame was defined as the frame before 
opening of the mitral valve.  The analysis was performed again for the 
group with DCM and LBBB.  Individual results are collated and Bland-
Altman plot displayed in Figures 5.10 to 5.17. 
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Figure 5.10 Bland-Altman plot for End Diastolic Volume
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Figure 5.12 Bland-Altman plot for Stroke Volume 
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Figure 5.14 Bland-Altman plot for SDI-I 
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Figure 5.16 Bland-Altman plot for GLS 
 
Figure 5.17 Bland-Altman plot for Twist 
 
In the majority of patients, the volumes agreed closely between the two 
groups, though there were a few outliers that combined with a small sample 
meant that the limits of agreement were high.  The mean EDV was 267.4ml, 
with a mean difference of 3.8ml, limits of agreement of 63ml; mean ESV 
219.9ml, mean difference 3.7ml, limits of agreement 60.4ml, mean stroke 
volume 47.5ml, mean difference 0ml limits of agreement 8.8ml and a mean 
EF of 18.9%, mean difference of 0%, limits of agreement 3.9%.  There were 
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mean difference 0.5%, limits of agreement 6.7% and SDI-II of 12.7%, mean 
difference 0.5%, limits of agreement 9.7%. Although the limits of 
agreement are likely to be an over-estimate given the sample size, 
nevertheless for the measures of dyssynchrony the limits of agreement 
approach the mean value calling into question their utility.   
The outlier datasets were reviewed and it became apparent that these 
datasets had the worst image quality.  Issues with image quality could be 
divided into a number of considerations, namely those with segmental 
dropout during at least part of the cardiac cycle or those due to poor 
myocardial definition such as a hazy ground glass appearance rather than a 
distinct specular pattern. 
In order to be able to use this method in a majority of patients, it was 
important to develop a tool that could work with real world datasets.  We 
therefore investigated if excluding poorly visualised segments from the 
analysis would improve the variability.  We also decided to recruit patients 
with perfect datasets, to ensure that the method was robust in perfect 
datasets. 
In the same cohort of patients with DCM and LBBB, the datasets were 
independently evaluated at both sites with regard to image quality and 
which segments should be excluded.  These assessments were exchanged 
between sites and reviewed to generate a common list of datasets and 
segments to exclude, which is listed in Table 5.2.  These datasets were 
analysed at both sites using the new speckle tracking software.  As a 
reference comparator, further analysis of the same datasets was performed 
at the Kings site by myself and Dr Stamatis Kapetanakis using the previous 
non-speckle tracking software (i.e.  the contour detection method as 
employed by the software package TomTec LV analysis 3.0).  As the focus 
was on dyssynchrony indices, only these data were received from the 
Chicago group.  These results are tabulated with Bland-Altman plots, 
  153 
correlation coefficients as well as intraclass correlation coefficients in 
Figures 5.18 to 5.20.  Using the new software, the mean difference +/- 
limits of agreement were 0.18% +/- 3.68%, 1.38% +/- 10.44%, −0.42% +/- 
13.00% for SDI-I, SDI-II and SDI of time to 3D minimum strain 
respectively.  Similarly, Intraclass correlation coefficients were 0.91, 0.75 
and 0.49 respectively.   
Using the contour detection method, the mean difference +/- limits of 
agreement were −2.36ml +/- 29.6ml for EDV, −0.91% +/- 6.5% for Ejection 
Fraction, and −0.52% +/- 3.6% for SDI-16, with intraclass correlation 



















1 OS 88 - 7,8 13,15 
2 PBH 2 3 9 13,14,1
6 
4 RH 69 2 8 13 
5 EH 48 2 8 13,14.1
6 
6 JD 65 - - 13,14,1
5,16 
7 EE 94 - 9 - 
8 MR 51 - 8 13,15 
9 EV 2 - 7,9 13,14,1
5 
10 AC 68 - - 15 
12 YC 78 - 8 13 
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Key to segments 
 
1 Basal anteroseptal 
2 Basal anterior 
3 Basal antero-lateral 
4 Basal infero-lateral 
5 Basal inferior 
6 Basal infero-septal 
7 Mid antero-septal 
8 Mid anterior 
9 Mid antero-lateral 
10 Mid infero-lateral 
11 Mid inferior 
12 Mid infero-septal 
13 Apical anterior 
14 Apical lateral 
15 Apical inferior 
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Figure 5.18 Bland-Altman plot for SDI-I
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Figure 5.20 Bland-Altman plot for SDI time to 3D minimum strain
 
5.5  Conclusions 
Speckle tracking is an attractive method to use in the analysis of left 
ventricular function in 3 dimensions.  It has a number of potentially useful 
characteristics over existing validated methods in that it is likely to track 
correctly in the area of papillary muscle insertion, as well as giving direct 
information about myocardial mechanics.  However, the development of 
software requires that the reproducibility of the technique is sufficiently 
good enough to produce reliable data.  The work delineated above 
describes the importance in standardising methods of analysis so that the 
reproducibility of the software analysis with clinical data can be explored.  
This work used 2 major versions of the software.  The first was an early 
software build with a different workflow to the second.  As the workflow 
was significantly simpler in the second major version, all datasets were 
reanalysed with this version.  We also found that using different software 
revisions of the same later version gave differing results, so the final 
comparison between centres ensured the software versions were the same.  
This is an important point for future studies highlighting that even minor 
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Initially, reproducibility between centres was poor when using different 
datasets of the same patient and different initialisation frames.  Once this 
had been standardised, it was discovered that reproducibility was poor 
when segments that were poorly visualised throughout the cardiac cycle or 
were noisy were included. 
When poor datasets and poorly visualised datasets were excluded from 
the analysis, reproducibility of the standard 3 dimensional dyssynchrony 
index was good (SDI-I, the standard deviation of the time to minimum 
volume of the included segments).  Reproducibility of strain based 
dyssynchrony indices (i.e. SDI-II and SDI of time to 3D minimum strain) 
was fair to poor. 
The Bland-Altman plot gives an easily comprehensible method for 
calculating any systematic bias between groups and the limits of agreement 
between groups but the limits of agreement will be wide in a small cohort.  
This work has therefore been continued by my colleagues to analyse the 
rest of the cohort of normal, DCM and normal with left bundle branch 
block patients, as well as to recruit more perfect datasets across these 
groups so that we can determine the reproducibility of the technique across 
a range of cardiac diseases in optimal circumstances.   
Further work to define the reproducibility of measurements within 
patients is also necessary before work on the clinical utility of these 
techniques is performed. 
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Chapter 6  Conclusions 
6.1  Aims of this thesis 
Three-dimensional echocardiography has emerged as a promising 
technique to investigate mechanical dyssynchrony and quantify left 
ventricular function.  The aim of this thesis was to utilise this technique to 
examine the effect of cardiac pacing on left ventricular function and in 
particular the optimisation of cardiac pacing with respect to site and timing.  
This thesis also investigated the reproducibility of three-dimensional 
echocardiographic speckle tracking across a range of patients. 
Four discrete projects were undertaken.  The first investigated three-
dimensional echocardiographic measurements with invasive measurements 
of left ventricular function including intra-cavitary left ventricular pressure 
measurements as well as impedance measurement between right and left 
ventricular pacing leads, performed during cardiac pacing.  The second 
project examined the effect of pacing the right ventricle as compared to 
intrinsic rhythm in patients paced from the mid-inter-ventricular septum or 
the right ventricular apex.  The third project examined the effect of 
biventricular pacing on left ventricular function serially in patients with an 
aim to investigate the utility of measurements to predict echocardiographic 
and clinical outcomes.  The final project examined the determinants of 
reproducibility of left ventricular function assessment using novel three-
dimensional echocardiographic speckle tracking. 
 
6.2  Summary of main findings 
The comparisons of three-dimensional echocardiographic assessments 
of left ventricular function with invasive measurements of dp/dt and 
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impedance have not previously been performed.  This study demonstrated 
that the agreement between these methods in the selection of optimal 
atrioventricular delays was poor.  There may be a number of reasons 
underlying this - intrinsic variability, alterations in loading situations, 
intrinsic variability on different days, or indeed limitations in the techniques 
investigated.  This may well explain why randomised controlled trials of 
echo methods to optimise atrioventricular delays have demonstrated little 
clinical benefit over default atrioventricular delay programming.  
Randomised controlled trials looking a clinical benefit for invasive 
measurements have not been performed, but the lack of agreement brings 
the question as to the reference standard for optimisation.  Given the lack of 
a reference method, the gold standard should remain long-term clinical 
outcome measures though that brings its own issues of measurement and 
unrelated health issues. 
The second study demonstrated that pacing results in impairment of left 
ventricular function when compared to intrinsic rhythm.  These data 
suggest that whilst pacing from the mid RV septum is equivalent to apical 
pacing in normal hearts; in patients with impaired LV function, mid-septal 
pacing results in a smaller fall in left ventricular ejection fraction compared 
to apical pacing.  This is the first study of the effects of mid-inter-ventricular 
pacing as an alternative site for right ventricular pacing using three 
dimensional echocardiography.  In the wider context, there is good data to 
indicate that conventional right ventricular apical pacing causes 
impairment in left ventricular function.  Since this study has been 
performed, biventricular pacing has been demonstrated to be better than 
right ventricular apical pacing in patients with impaired LV function167.  
Furthermore the results of PROTECT-PACE trial have been published177, 
which demonstrated that in patients with normal left ventricular function 
and requiring a high percentage of ventricular pacing, right ventricular 
apical pacing was equivalent to right ventricular outflow tract pacing.  In 
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both groups there was a decrease in left ventricular ejection fraction of 2%.  
Smaller trials have demonstrated that mid-ventricular pacing is comparable 
to apical pacing in patients with preserved left ventricular function using 
nuclear medicine techniques178.  Haemodynamic data suggest that the 
basal-mid septum is the most favourable site for RV pacing179. 
Our data suggests that mid inter-ventricular septal pacing is superior to 
apical pacing in impaired LV function, but the question remains as to 
whether mid-septal pacing, or indeed right ventricular outflow tract pacing 
is equivalent to biventricular pacing in impaired LV function.  A single 
recent study has attempted to answer this by measuring the ejection fraction 
in 22 patients scheduled for CRT.  They underwent temporary dual 
chamber pacing prior to CRT.  They found that both right ventricular 
outflow tract and mid-septal pacing were superior to apical pacing, but that 
biventricular pacing was better still180. 
The third study investigated the utility of the change in dyssynchrony in 
predicting response to CRT and to CRT optimisation.  We found that the 
change in dyssynchrony was a better predictor of response to CRT than 
baseline dyssynchrony, or other conventional selection criteria.  We found 
that patients who were not dyssynchronous after CRT had little benefit from 
CRT optimisation.  We confirmed the importance of LBBB, female sex, 
sinus rhythm, non-ischaemic aetiology in predicting a better outcome from 
CRT.  This investigation confirms the importance of dyssynchrony as an 
important determinant in the response to CRT.  We have confirmed prior 
work on the utility of baseline dyssynchrony measures in predicting 
outcome, but have also demonstrated that improvement in dyssynchrony 
after CRT is a better predictor of echocardiographic response than baseline 
measurements.  We have also used three-dimensional echocardiography as 
an independent method of assessing the immediate response to Doppler 
echo-guided CRT optimisation.  We confirm that optimisation makes a 
clinically significant difference to left ventricular function in a few patients, 
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but that the majority of patients see little acute benefit.  The presence of 
dyssynchrony after CRT implantation may be a useful marker to select 
patients with a higher probability of responding to CRT optimisation. 
Finally a series of investigations were performed using speckle tracking 
software.  Although this has excellent reproducibility for volumes, 
dyssynchrony assessment was less reliable.  We demonstrated that the 
removal of imperfectly visualised segments and standardisation of 
technique led to greater reproducibility.  The applicability of this technique 
as investigated in this study is unlikely to be broad given the issues with 
image quality, however, it does demonstrate that the technique could be 
improved by the ability to identify and exclude poorly visualised segments.  
Further software development may improve the tracking ability as well as 
automatic identification of poorly visualised segments.   This work 
highlights the necessity of training programs to ensure reliability in 
measurements and this work has been extended by colleagues181.   
6.3  Conclusion 
Real time 3 dimensional echocardiography has proven to be a valuable 
technique for the accurate measurement of ejection fraction and in the 
assessment of left ventricular dyssynchrony.  Current guidelines do not 
recommend echocardiographic indices of dyssynchrony be used for patient 
selection for CRT.  These data show that this technique may give valuable 
information that helps guide treatment for patients.  Novel 3 dimensional 
speckle tracking software requires refinement to improve its reproducibility 
and reliability for dyssynchrony assessments, though it is promising for the 
measurement of left ventricular volumes. 
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